SECURITIES PURCHASE AGREEMENT
EXECUTION
VERSION
This
Securities Purchase Agreement is entered into and dated as of September 22,
2005 (this “Agreement”),
by
and among American United Global, Inc., a Delaware corporation (the
“Company”),
and
each of the purchasers identified on the signature pages hereto (each, a
“Purchaser”
and
collectively, the “Purchasers”).
WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant
to
Section 4(2) of the Securities Act of 1933 (the “Securities
Act”),
and
Rule 506 promulgated thereunder, the Company desires to issue and sell to
each
Purchaser, and each Purchaser, severally and not jointly, desires to purchase
from the Company, certain securities of the Company pursuant to the terms
set
forth herein.
NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement,
and for other good and valuable consideration, the receipt and adequacy of
which
are hereby acknowledged, the Company and each Purchaser, severally and not
jointly, agree as follows:
ARTICLE
I.
DEFINITIONS
1.1 Definitions.
In
addition to the terms defined elsewhere in this Agreement, the following
terms
shall have the meanings set forth in this Section 1.1:
“Affiliate”
means
any Person that, directly or indirectly through one or more intermediaries,
controls or is controlled by or is under common control with a Person, as
such
terms are used in and construed under Rule 144 under the Securities Act.
With
respect to a Purchaser, any investment fund or managed account that is managed
on a discretionary basis by the same investment manager as such Purchaser
will
be deemed to be an Affiliate of such Purchaser.
“Bankruptcy
Event”
means
any of the following events: (a) the Company or any Subsidiary commences
a case
or other proceeding under any bankruptcy, reorganization, arrangement,
adjustment of debt, relief of debtors, dissolution, insolvency or liquidation
or
similar law of any jurisdiction relating to the Company or any Subsidiary
thereof; (b) there is commenced against the Company or any Subsidiary any
such
case or proceeding that is not dismissed within 60 days after commencement;
(c)
the Company or any Subsidiary is adjudicated insolvent or bankrupt or any
order
of relief or other order approving any such case or proceeding is entered;
(d)
the Company or any Subsidiary suffers any appointment of any custodian or
the
like for it or any substantial part of its property that is not discharged
or
stayed within 60 days; (e) the Company or any Subsidiary makes a general
assignment for the benefit of creditors; (f) the Company or any Subsidiary
fails
to pay, or states that it is unable to pay or is unable to pay, its debts
generally as they become due; (g) the Company or any Subsidiary calls a meeting
of its creditors with a view to arranging a composition, adjustment or
restructuring of its debts; or (h) the Company or any Subsidiary, by any
act or
failure to act, expressly indicates its consent to, approval of or acquiescence
in any of the foregoing or takes any corporate or other action for the purpose
of effecting any of the foregoing.
“Business
Day”
means
any day except Saturday, Sunday and any day which shall be a federal legal
holiday or a day on which banking institutions in the State of New York are
authorized or required by law or other governmental action to
close.
“Change
of Control”
means
the occurrence of any of the following in one or a series of related
transactions: (i) an acquisition after the date hereof by an individual or
legal
entity or “group” (as described in Rule 13d-5(b)(1) under the Exchange Act) of
more than one-third of the voting rights or equity interests in the Company;
(ii) a replacement of more than one-half of the members of the Company’s board
of directors that is not approved by those individuals who are members of
the
board of directors on the date hereof (or other directors previously approved
by
such individuals); (iii) a merger or consolidation of the Company or any
Subsidiary or a sale of more than one-third of the assets of the Company
in one
or a series of related transactions, unless following such transaction or
series
of transactions, the holders of the Company’s securities prior to the first such
transaction continue to hold at least two-thirds of the voting rights and
equity
interests in of the surviving entity or acquirer of such assets; (iv) a
recapitalization, reorganization or other transaction involving the Company
or
any Subsidiary that constitutes or results in a transfer of more than one-third
of the voting rights or equity interests in the Company; (v) consummation
of a
“Rule 13e-3 transaction” as defined in Rule 13e-3 under the Exchange Act with
respect to the Company, or (vi) the execution by the Company or its controlling
shareholders of an agreement providing for or reasonably likely to result
in any
of the foregoing events.
“Closing”
means
the closing of the purchase and sale of the Securities pursuant to Section
2.1.
“Closing
Date”
means
the date of the Closing.
“Closing
Price”
means,
for any date, the price determined by the first of the following clauses
that
applies: (a) if the Common Stock is then listed or quoted on an Eligible
Market
or any other national securities exchange, the closing bid price per share
of
the Common Stock for such date (or the nearest preceding date) on the primary
Eligible Market or exchange on which the Common Stock is then listed or quoted;
(b) if prices for the Common Stock are then quoted on the OTC Bulletin Board,
the closing bid price per share of the Common Stock for such date (or the
nearest preceding date) so quoted; (c) if prices for the Common Stock are
then
reported in the “Pink Sheets” published by the National Quotation Bureau
Incorporated (or a similar organization or agency succeeding to its functions
of
reporting prices), the most recent bid price per share of the Common Stock
so
reported; or (d) in all other cases, the fair market value of a share of
Common
Stock as determined by an independent appraiser selected in good faith by
a
majority in interest of the Purchasers.
“Commission”means
the
Securities and Exchange Commission.
“Common
Stock”
means
the common stock of the Company, par value $0.01 per share, and any securities
into which such common stock may hereafter be reclassified.
2
“Common
Stock Equivalents”
means,
collectively, Options and Convertible Securities.
“Company
Counsel”
means
Sichenzia Xxxx Xxxxxxxx Xxxxxxx LLP, counsel to the Company.
“Conversion
Price”
has the
meaning set forth in the Notes.
“Convertible
Securities”
means
any stock or securities (other than Options) convertible into or exercisable
or
exchangeable for Common Stock.
“Effective
Date”
means
the date that the Registration Statement is first declared effective by the
Commission.
“Eligible
Market”
means
any of the New York Stock Exchange, the American Stock Exchange, the Nasdaq
National Market or the Nasdaq SmallCap Market.
“Exchange
Act”
means
the Securities Exchange Act of 1934, as amended.
“Excluded
Stock”
means
the issuance of Common Stock (A) upon exercise or conversion of any options
or
other securities described in Schedule 3.1(g) (provided that such exercise
or
conversion occurs in accordance with the terms thereof, without amendment
or
modification); (B) in connection with any issuance of shares or grant of
options
to employees, officers, directors or consultants of the Company pursuant
to a
stock option plan or other incentive stock plan duly or otherwise pursuant
to
any employee benefit plan described in Schedule 3.1(g) or hereafter adopted
by
the Company and approved by its shareholders or in respect of the issuance
of
Common Stock upon exercise of any such options
or (C)
in connection with the issuance of 400,000 shares of Common Stock to purchasers
(other than in connection with the Kraft Financing) at a purchase price of
$0.50
per share which such issuance shall occur within 45 days of the Closing Date.
“Filing
Date”
means
the earlier of (a) the 30th
day
following the completion of the Kraft Financing and (b) the 90th day following
the Closing Date with respect to the initial Registration Statement required
to
be filed hereunder, and, with respect to any additional Registration Statements
that may be required pursuant to Section
6.1(f),
the
10th day following the date on which the Company first knows, or reasonably
should have known, that such additional Registration Statement is required
under
such Section.
“Kraft
Financing”means
the
convertible debentures in the aggregate principal amount of up to seven million
five hundred thousand dollars ($7,500,000) convertible into shares of Common
Stock upon terms similar to those contained in the Notes which such securities
are to be issued in connection with the acquisition of Xxxxx Xx., a Hungarian
corporation.
“Losses”
means
any and all losses, claims, damages, liabilities, settlement costs and expenses,
including without limitation costs of preparation of legal action and reasonable
attorneys’ fees.
3
“Notes”
means
the Senior Secured Convertible Notes due March 22, 2007 with an aggregate
principal face amount of $525,000 issued by the Company to the Purchasers
hereunder in the form of Exhibit
A
hereto.
“Options”
means
any rights, warrants or options to subscribe, directly or indirectly for
or
purchase Common Stock or Convertible Securities.
“Person”
means an
individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any
kind.
“Proceeding”
means an
action, claim, suit, investigation or proceeding (including, without limitation,
an investigation or partial proceeding, such as a deposition), whether commenced
or threatened.
“Prospectus”
means
the prospectus included in the Registration Statement (including, without
limitation, a prospectus that includes any information previously omitted
from a
prospectus filed as part of an effective registration statement in reliance
upon
Rule 430A promulgated under the Securities Act), as amended or supplemented
by
any prospectus supplement, with respect to the terms of the offering of any
portion of the Registrable Securities covered by the Registration Statement,
and
all other amendments and supplements to the Prospectus including post effective
amendments, and all material incorporated by reference or deemed to be
incorporated by reference in such Prospectus.
“Purchaser
Counsel”
means
Proskauer Rose LLP, counsel to Iroquois Master Fund Ltd.
“Registrable
Securities”
means
any Common Stock (including Underlying Shares) issued or issuable pursuant
to
the Transaction Documents, together with any securities issued or issuable
upon
any stock split, dividend or other distribution, recapitalization or similar
event with respect to the foregoing.
“Registration
Statement”
means
the initial registration statement required to be filed under Article VI
and any
additional registration statements contemplated by Section 6.1(f), including
(in
each case) the Prospectus, amendments and supplements to such registration
statement or Prospectus, including pre- and post-effective amendments, all
exhibits thereto, and all material incorporated by reference or deemed to
be
incorporated by reference in such registration statement.
“Required
Effectiveness Date”
means
(i) with respect to the initial Registration Statement required to be filed
hereunder, the 135th day following the Closing Date and (ii) with respect
to any
additional Registration Statements that may be required pursuant to Section
6.1(f),
the
45th day following the date on which the Company first knows, or reasonably
should have known, that such additional Registration Statement is required
under
such Section.
“Rule
144,” “Rule
415,”
and
“Rule
424”
means
Rule 144, Rule 415 and Rule 424, respectively, promulgated by the Commission
pursuant to the Securities Act, as such Rules may be amended from time to
time,
or any similar rule or regulation hereafter adopted by the Commission having
substantially the same effect as such Rule.
4
“Securities”
means
the Notes, Common Stock and the Underlying Shares issued or issuable (as
applicable) to the applicable Purchaser pursuant to the Transaction Documents.
“Securities
Act”
means
the Securities Act of 1933, as amended.
“Security
Agreement”
means
that certain Security Agreement, dated as of the Closing Date, by and among
the
Company, Iroquois Master Fund Ltd. and each of the Purchasers, as the same
be
amended, modified or supplemented from time to time, substantially in the
form
of Exhibit
B.
“Shares”
means
the shares of Common Stock issued by the Company to the Purchasers hereunder,
not including the Underlying Shares.
“Subsidiary”
means
any subsidiary of the Company that is required to be listed on Schedule
3.1(a).
“Trading
Day”
means
(a) any day on which the Common Stock is listed or quoted and traded on its
primary Trading Market, or (b) if the Common Stock is not then listed or
quoted
and traded on any Trading Market, then any Business Day.
“Trading
Market”
means
Nasdaq SmallCap Market or any other Eligible Market or any national securities
exchange, market or trading or quotation facility on which the Common Stock
is
then listed or quoted.
“Transaction
Documents”
means
this Agreement, the Security Agreement, the Notes, the Transfer Agent
Instructions and any other documents or agreements executed or delivered
in
connection with the transactions contemplated hereby.
“Transfer
Agent Instructions”
means
the Company’s transfer agent instructions in the form of Exhibit
C.
“Underlying
Shares”
means
the shares of Common Stock issuable (i) upon conversion of the Notes
and
(ii) in satisfaction of any other obligation of the Company to issue
shares of Common Stock pursuant to the Transaction Documents, and in each
case,
any securities issued or issuable in exchange for or in respect of such
securities.
“VWAP”
means on
any particular Trading Day or for any particular period the volume weighted
average trading price per share of Common Stock on such date or for such
period
on an Eligible Market as reported by Bloomberg L.P., or any successor performing
similar functions; provided,
however,
that
during any period the VWAP is being determined, the VWAP shall be subject
to
adjustment from time to time for stock splits, stock dividends, combinations
and
similar events as applicable.
5
ARTICLE
II.
PURCHASE
AND SALE
2.1 Closing.
Subject
to the terms and conditions set forth in this Agreement, at the Closing,
the
Company shall issue and sell to each Purchaser, and each Purchaser shall,
severally and not jointly, purchase from the Company, the Notes and the Shares
for the aggregate purchase price set forth below such Purchaser’s name on the
signature pages hereto. The Closing shall take place at the offices of Purchaser
Counsel or at such other location or time as the parties may agree.
2.2 Closing
Deliveries.
(a)
At
the
Closing, the Company shall deliver or cause to be delivered to each Purchaser
the following:
(i) a
Note,
registered in the name of such Purchaser, in the principal amount indicated
below such Purchaser’s name on the signature page of this Agreement under the
heading “Note Principal Amount”;
(ii) a
stock
certificate, registered in the name of such Purchaser, in an amount indicated
below such Purchaser’s name on the signature page of this Agreement under the
heading “Shares”.
(iii) the
legal
opinion of Company Counsel, in the form of Exhibit
D,
executed by such counsel and delivered to the Purchasers;
(iv) the
Transfer Agent Instructions duly executed by the Company and acknowledged
by the
Company’s transfer agent;
(v) the
Security Agreement duly executed by the Company in favor of the Purchaser;
(vi) proper
financing statements in form appropriate for filing under the Uniform Commercial
Code of all jurisdictions that the Purchasers may reasonably deem necessary
or
desirable in order to perfect and protect the liens and security interests
created under the Security Agreement, covering the collateral described in
the
Security Agreement;
(vii) a
personal guaranty executed by Xxxxxx Xxxxx (“Xxxxx”)
in
favor of the Purchasers in the form attached hereto as Exhibit
F;
and
(viii) any
other
document reasonably requested by the Purchasers or Purchaser
Counsel.
(b)
At
the
Closing, each Purchaser shall deliver or cause to be delivered to the Company
the following
(i) the
purchase price indicated below such Purchaser’s name on the signature page of
this Agreement under the heading “Purchase Price”, in United States dollars and
in immediately available funds, by wire transfer to an account designated
in
writing by the Company for such purpose; and
(ii) the
Security Agreement duly executed by such Purchaser.
6
ARTICLE
III.
REPRESENTATIONS
AND WARRANTIES
3.1 Representations
and Warranties of the Company.
The
Company hereby makes the following representations and warranties to the
Purchasers:
(a)
Subsidiaries.
The
Company does not directly or indirectly control or own any interest in any
other
corporation, partnership, joint venture or other business association or
entity
(a “Subsidiary”),
other
than those listed in Schedule 3.1(a). Except as disclosed in Schedule 3.1(a),
the Company owns, directly or indirectly, all of the capital stock of each
Subsidiary free and clear of any lien, charge, claim, security interest,
encumbrance, right of first refusal or other restriction (collectively,
“Liens”),
and
all the issued and outstanding shares of capital stock of each Subsidiary
are
validly issued and are fully paid, non-assessable and free of preemptive
and
similar rights.
(b)
Organization
and Qualification.
Each of
the Company and the Subsidiaries is an entity duly incorporated or otherwise
organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation or organization (as applicable), with the
requisite power and authority to own and use its properties and assets and
to
carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation of any of the provisions of its respective
certificate or articles of incorporation, bylaws or other organizational
or
charter documents. Each of the Company and the Subsidiaries is duly qualified
to
conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted
or
property owned by it makes such qualification necessary, except where the
failure to be so qualified or in good standing, as the case may be, could
not,
individually or in the aggregate, (i) adversely affect the legality, validity
or
enforceability of any Transaction Document, (ii) have or result in a material
adverse effect on the results of operations, assets, prospects, business
or
condition (financial or otherwise) of the Company and the Subsidiaries, taken
as
a whole, or (iii) adversely impair the Company’s ability to perform fully on a
timely basis its obligations under any Transaction Document (any of (i),
(ii) or
(iii), a “Material
Adverse Effect”).
(c)
Authorization;
Enforcement.
The
Company has the requisite corporate power and authority to enter into and
to
consummate the transactions contemplated by each of the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of each of the Transaction Documents by the Company
and
the consummation by it of the transactions contemplated hereunder and thereunder
have been duly authorized by all necessary action on the part of the Company
and
no further consent or action is required by the Company, its Board of Directors
or its stockholders. Each Transaction Document has been (or upon delivery
will
have been) duly executed by the Company and, when delivered in accordance
with
the terms hereof, will constitute the valid and binding obligation of the
Company enforceable against the Company in accordance with its terms. Neither
the Company nor any Subsidiary is in violation of any of the provisions of
its
certificate or articles of incorporation, by laws or other organizational
or
charter documents.
7
(d)
No
Conflicts.
The
execution, delivery and performance of the Transaction Documents by the Company
and the consummation by the Company of the transactions contemplated hereby
do
not and will not (i) conflict with or violate any provision of the Company’s or
any Subsidiary’s certificate or articles of incorporation, bylaws or other
organizational or charter documents, or (ii) conflict with, or constitute
a
default (or an event that with notice or lapse of time or both would become
a
default) under, or give to others any rights of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time or both)
of,
any agreement, credit facility, debt or other instrument (evidencing a Company
or Subsidiary debt or otherwise) or other understanding to which the Company
or
any Subsidiary is a party or by which any property or asset of the Company
or
any Subsidiary is bound or affected, or (iii) result in a violation of any
law,
rule, regulation, order, judgment, injunction, decree or other restriction
of
any court or governmental authority to which the Company or a Subsidiary
is
subject (including federal and state securities laws and regulations), or
by
which any property or asset of the Company or a Subsidiary is bound or affected;
except as do not, individually or in the aggregate, have or are reasonably
be
expected to result in a Material Adverse Effect.
(e)
Filings,
Consents and Approvals.
The
Company is not required to obtain any consent, waiver, authorization or order
of, give any notice to, or make any filing or registration with, any court
or
other federal, state, local or other governmental authority or other Person
in
connection with the execution, delivery and performance by the Company of
the
Transaction Documents, other than the filing with the Commission of the
Registration Statement, the application(s) to each Trading Market for the
listing of the Underlying Shares for trading thereon in the time and manner
required thereby, and applicable Blue Sky filings (collectively, the “Required
Approvals”).
(f)
Issuance
of the Securities.
The
Securities have been duly authorized. The Notes and the Shares have been,
and
the Underlying Shares or other securities issuable upon conversion of the
Notes,
when so issued in accordance with the terms of the Notes will be, validly
issued. The Notes and the Shares are, and the Underlying Shares or other
securities issuable upon conversion of the Notes, when so issued in accordance
with the terms of the Notes will be, fully paid and nonassessable and free
of
preemptive or similar rights. The Notes and the Shares have been, and the
Underlying Shares or other securities issuable upon conversion of the Notes,
when so issued in accordance with the terms of the Notes will be, issued
in
compliance with applicable securities laws, rules and regulations. The Company
has reserved from its duly authorized capital stock the maximum number of
shares
of Common Stock to be issued to the applicable Purchasers upon conversion
of the
Notes or issuable pursuant to the other Transaction Documents.
(g)
Capitalization.
The
number of shares and type of all authorized, issued and outstanding capital
stock of the Company is set forth in Schedule
3.1(g).
No
securities of the Company are entitled to preemptive or similar rights, and
no
Person has any right of first refusal, preemptive right, right of participation,
or any similar right to participate in the transactions contemplated by the
Transaction Documents. Except as a result of the purchase and sale of the
Securities and except as disclosed in Schedule
3.1(g),
there
are no outstanding options, warrants, script rights to subscribe to, calls
or
commitments of any character whatsoever relating to, or securities, rights
or
obligations convertible into or exchangeable for, or giving any Person any
right
to subscribe for or acquire, any shares of Common Stock, or contracts,
commitments, understandings or arrangements by which the Company or any
Subsidiary is or may become bound to issue additional shares of Common Stock,
or
securities or rights convertible or exchangeable into shares of Common Stock.
The issue and sale of the Securities will not obligate the Company to issue
shares of Common Stock or other securities to any Person (other than the
Purchasers) and will not result in a right of any holder of Company securities
to adjust the exercise, conversion, exchange or reset price under such
securities.
8
(h)
SEC
Reports; Financial Statements.
Except
as disclosed in Schedule
3.1(h),
the
Company has filed all reports required to be filed by it under the Securities
Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof,
for the two years preceding the date hereof (or such shorter period as the
Company was required by law to file such material) (the foregoing materials
being collectively referred to herein as the “SEC
Reports”
and,
together with the Schedules to this Agreement, the “Disclosure
Materials”)
on a
timely basis or has received a valid extension of such time of filing and
has
filed any such SEC Reports prior to the expiration of any such extension.
The
Company has delivered to the Purchasers a copy of all SEC Reports filed within
the 10 days preceding the date hereof. As of their respective dates, the
SEC
Reports complied in all material respects with the requirements of the
Securities Act and the Exchange Act and the rules and regulations of the
Commission promulgated thereunder, and none of the SEC Reports, when filed,
contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading. The financial statements of the Company included in the SEC Reports
comply in all material respects with applicable accounting requirements and
the
rules and regulations of the Commission with respect thereto as in effect
at the
time of filing. Such financial statements have been prepared in accordance
with
generally accepted accounting principles applied on a consistent basis during
the periods involved (“GAAP”),
except as may be otherwise specified in such financial statements or the
notes
thereto, and fairly present in all material respects the financial position
of
the Company and its consolidated subsidiaries as of and for the dates thereof
and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, immaterial, year-end
audit adjustments.
(i)
Material
Changes.
Since
the date of the latest audited financial statements included within the SEC
Reports, except as specifically disclosed in the SEC Reports, (i) there has
been
no event, occurrence or development that has had or that could reasonably
be
expected to result in a Material Adverse Effect, (ii) the Company has not
incurred any liabilities (contingent or otherwise) other than (A) trade payables
and accrued expenses incurred in the ordinary course of business consistent
with
past practice and (B) liabilities not required to be reflected in the Company’s
financial statements pursuant to GAAP or required to be disclosed in filings
made with the Commission, (iii) the Company has not altered its method of
accounting or the identity of its auditors, (iv) the Company has not declared
or
made any dividend or distribution of cash or other property to its stockholders
or purchased, redeemed or made any agreements to purchase or redeem any shares
of its capital stock, and (v) the Company has not issued any equity securities
to any officer, director or Affiliate, except pursuant to existing Company
stock
option plans. The Company does not have pending before the Commission any
request for confidential treatment of information.
9
(j)
Litigation.
Except
as disclosed in Schedule
3.1(j),
there
is no action, suit, inquiry, notice of violation, proceeding or investigation
pending or, to the knowledge of the Company, threatened against or affecting
the
Company, any Subsidiary or any of their respective properties before or by
any
court, arbitrator, governmental or administrative agency or regulatory authority
(federal, state, county, local or foreign) (collectively, an “Action”)
which
(i) adversely affects or challenges the legality, validity or enforceability
of
any of the Transaction Documents or the Securities or (ii) could, if there
were
an unfavorable decision, individually or in the aggregate, have or result
in a
Material Adverse Effect. Neither the Company nor any Subsidiary, nor any
director or officer thereof, is or has been the subject of any Action involving
a claim of violation of or liability under federal or state securities laws
or a
claim of breach of fiduciary duty. There has not been, and to the knowledge
of
the Company, there is not pending or contemplated, any investigation by the
Commission involving the Company or any current or former director or officer
of
the Company. The Commission has not issued any stop order or other order
suspending the effectiveness of any registration statement filed by the Company
or any Subsidiary under the Exchange Act or the Securities Act.
(k)
Labor
Relations.
No
material labor dispute exists or, to the knowledge of the Company, is imminent
with respect to any of the employees of the Company.
(l)
Compliance.
Neither
the Company nor any Subsidiary (i) is in default under or in violation of
(and
no event has occurred that has not been waived that, with notice or lapse
of
time or both, would result in a default by the Company or any Subsidiary
under),
nor has the Company or any Subsidiary received notice of a claim that it
is in
default under or that it is in violation of, any indenture, loan or credit
agreement or any other agreement or instrument to which it is a party or
by
which it or any of its properties is bound (whether or not such default or
violation has been waived), (ii) is in violation of any order of any court,
arbitrator or governmental body, or (iii) is or has been in violation of
any
statute, rule or regulation of any governmental authority, including without
limitation all foreign, federal, state and local laws relating to taxes,
environmental protection, occupational health and safety, product quality
and
safety and employment and labor matters, except in each case as does not,
individually or in the aggregate, have or reasonably be expected to result
in a
Material Adverse Effect.
(m)
Regulatory
Permits.
The
Company and the Subsidiaries possess all certificates, authorizations and
permits issued by the appropriate federal, state, local or foreign regulatory
authorities necessary to conduct their respective businesses as described
in the
SEC Reports, except where the failure to possess such permits could not,
individually or in the aggregate, have or result in a Material Adverse Effect
(“Material
Permits”),
and
neither the Company nor any Subsidiary has received any notice of proceedings
relating to the revocation or modification of any Material Permit.
(n)
Title
to Assets.
The
Company and the Subsidiaries have good and marketable title in fee simple
to all
real property owned by them that is material to the business of the Company
and
the Subsidiaries and good and marketable title in all personal property owned
by
them that is material to the business of the Company and the Subsidiaries,
in
each case free and clear of all Liens, except for Liens as do not materially
affect the value of such property and do not materially interfere with the
use
made and proposed to be made of such property by the Company and the
Subsidiaries. Any real property and facilities held under lease by the Company
and the Subsidiaries are held by them under valid, subsisting and enforceable
leases of which the Company and the Subsidiaries are in compliance.
10
(o)
Patents
and Trademarks.
The
Company and the Subsidiaries have, or have rights to use, all patents, patent
applications, trademarks, trademark applications, service marks, trade names,
copyrights, licenses and other similar rights that are necessary or material
for
use in connection with their respective businesses as described in the SEC
Reports and which the failure to so have could have a Material Adverse Effect
(collectively, the “Intellectual
Property Rights”).
Neither the Company nor any Subsidiary has received a written notice that
the
Intellectual Property Rights used by the Company or any Subsidiary violates
or
infringes upon the rights of any Person. To the knowledge of the Company,
all
such Intellectual Property Rights are enforceable and there is no existing
infringement by another Person of any of the Intellectual Property
Rights.
(p)
Insurance.
The
Company and the Subsidiaries are insured by insurers of recognized financial
responsibility against such losses and risks and in such amounts as are prudent
and customary in the businesses in which the Company and the Subsidiaries
are
engaged. Neither the Company nor any Subsidiary has any reason to believe
that
it will not be able to renew its existing insurance coverage as and when
such
coverage expires or to obtain similar coverage from similar insurers as may
be
necessary to continue its business without a significant increase in
cost.
(q)
Transactions
With Affiliates and Employees.
Except
as set forth in SEC Reports, none of the officers or directors of the Company
and, to the knowledge of the Company, none of the employees of the Company
is
presently a party to any transaction with the Company or any Subsidiary (other
than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to
or
by, providing for rental of real or personal property to or from, or otherwise
requiring payments to or from any officer, director or such employee or,
to the
knowledge of the Company, any entity in which any officer, director, or any
such
employee has a substantial interest or is an officer, director, trustee or
partner.
(r)
Internal
Accounting Controls.
The
Company and the Subsidiaries maintain a system of internal accounting controls
sufficient to provide reasonable assurance that (i) transactions are executed
in
accordance with management’s general or specific authorizations, (ii)
transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability,
(iii)
access to assets is permitted only in accordance with management’s general or
specific authorization, and (iv) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate
action
is taken with respect to any differences.
(s)
Solvency.
Based
on the financial condition of the Company as of the Closing Date, (i) the
Company’s fair saleable value of its assets exceeds the amount that will be
required to be paid on or in respect of the Company’s existing debts and other
liabilities (including known contingent liabilities) as they mature; (ii)
the
Company’s assets do not constitute unreasonably small capital to carry on its
business for the current fiscal year as now conducted and as proposed to
be
conducted including its capital needs taking into account the particular
capital
requirements of the business conducted by the Company, and projected capital
requirements and capital availability thereof; and (iii) the current cash
flow
of the Company, together with the proceeds the Company would receive, were
it to
liquidate all of its assets, after taking into account all anticipated uses
of
the cash, would be sufficient to pay all amounts on or in respect of its
debt
when such amounts are required to be paid. The Company does not intend to
incur
debts beyond its ability to pay such debts as they mature (taking into account
the timing and amounts of cash to be payable on or in respect of its
debt).
11
(t)
Certain
Fees.
Except
as described in Schedule
3.1(t),
no
brokerage or finder’s fees or commissions are or will be payable by the Company
to any broker, financial advisor or consultant, finder, placement agent,
investment banker, bank or other Person with respect to the transactions
contemplated by this Agreement. The Purchasers shall have no obligation with
respect to any fees or with respect to any claims made by or on behalf of
other
Persons for fees of a type contemplated in this Section that may be due in
connection with the transactions contemplated by this Agreement. The Company
shall indemnify and hold harmless the Purchasers, their employees, officers,
directors, agents, and partners, and their respective Affiliates, from and
against all claims, losses, damages, costs (including the costs of preparation
and attorney’s fees) and expenses suffered in respect of any such claimed or
existing fees, as such fees and expenses are incurred.
(u)
Private
Placement.
No
registration under the Securities Act is required for the offer and sale
of the
Securities by the Company to the Purchasers as contemplated hereby. The issuance
and sale of the Securities hereunder does not contravene the rules and
regulations of the Trading Market and no shareholder approval is required
for
the Company to fulfill its obligations under the Transaction
Documents.
(v)
Form
S-3 Eligibility.
The
Company is eligible to register the resale of its Common Stock for resale
by the
Purchasers under Form S-3 promulgated under the Securities Act (or if the
Company is not eligible for the use of Form S-3, the Company may use the
form of
registration for which it is eligible at that time).
(w)
Listing
and Maintenance Requirements.
Except
as disclosed in Schedule
3.1(w),
the
Company has not, in the two years preceding the date hereof, received notice
(written or oral) from any Eligible Market on which the Common Stock is or
has
been listed or quoted to the effect that the Company is not in compliance
with
the listing or maintenance requirements of such Eligible Market. The Company
is,
and has no reason to believe that it will not in the foreseeable future continue
to be, in compliance with all such listing and maintenance
requirements.
(x)
Registration
Rights.
Except
as described in Schedule
3.1(x),
the
Company has not granted or agreed to grant to any Person any rights (including
“piggy back” registration rights) to have any securities of the Company
registered with the Commission or any other governmental authority that have
not
been satisfied.
12
(y)
Application
of Takeover Protections.
The
Company and its Board of Directors have taken all necessary action, if any,
in
order to render inapplicable any control share acquisition, business
combination, poison pill (including any distribution under a rights agreement)
or other similar anti takeover provision under the Company’s Certificate of
Incorporation (or similar charter documents) or the laws of its state of
incorporation that is or could become applicable to the Purchasers as a result
of the Purchasers and the Company fulfilling their obligations or exercising
their rights under the Transaction Documents, including without limitation
the
Company’s issuance of the Securities and the Purchasers’ ownership of the
Securities.
(z)
Disclosure.
The
Company confirms that neither it nor any other Person acting on its behalf
has
provided any of the Purchasers or their agents or counsel with any information
that constitutes or might constitute material, nonpublic information. The
Company understands and confirms that each of the Purchasers will rely on
the
foregoing representations in effecting transactions in securities of the
Company. All disclosure materials provided to the Purchasers regarding the
Company, its business and the transactions contemplated hereby, including
the
Schedules to this Agreement, furnished by or on behalf of the Company are
true
and correct in all material respects and do not contain any untrue statement
of
a material fact or omit to state any material fact necessary in order to
make
the statements made therein, in the light of the circumstances under which
they
were made, not misleading; it being understood that the Company has not provided
the Purchasers, and the Purchasers are not relying on, any information
constituting a forecast or projection. No event or circumstance has occurred
or
information exists with respect to the Company or any of its Subsidiaries
or its
or their business, properties, prospects, operations or financial conditions,
which, under applicable law, rule or regulation, requires public disclosure
or
announcement by the Company but which has not been so publicly announced
or
disclosed. The Company acknowledges and agrees that (i) no Purchaser makes
or
has made any representations or warranties with respect to the transactions
contemplated hereby other than those specifically set forth in Section 3.2
or
(ii) any statement, commitment or promise to the Company or, to its knowledge,
any of its representatives which is or was an inducement to the Company to
enter
into this Agreement or otherwise.
(aa)
No
Violation.
The
issuance and sale of the Securities contemplated hereby does not conflict
with
or violate any rules or regulations of the Trading Market.
(bb)
Acknowledgment
Regarding Purchasers’ Purchase of Securities.
The
Company acknowledges and agrees that each of the Purchasers is acting solely
in
the capacity of an arm’s length purchaser with respect to this Agreement and the
transactions contemplated hereby. The Company further acknowledges that no
Purchaser is acting as a financial advisor or fiduciary of the Company or
any
other Purchaser (or in any similar capacity) with respect to this Agreement
and
the transactions contemplated hereby and any advice given by any Purchaser
or
any of their respective representatives or agents in connection with this
Agreement and the transactions contemplated hereby is merely incidental to
such
Purchaser’s purchase of the Securities. The Company further represents to each
Purchaser that the Company’s decision to enter into this Agreement has been
based solely on the independent evaluation of the Company and its
representatives. The Company further acknowledges that no Purchaser has made
any
promises or commitments other than as set forth in this Agreement, including
any
promises or commitments for any additional investment by any such Purchaser
in
the Company.
13
(cc)
Investment
Company.
The
Company is not, and is not an Affiliate of, an investment company within
the
meaning of the Investment Company Act of 1940, as amended.
(dd)
Ranking.
Except
as set forth on Schedule 3.1(dd), as of the date of this Agreement, no
indebtedness of the Company is senior to or pari passu with the Notes in
right
of payment, whether with respect to principal, interest or upon liquidation
or
dissolution, or otherwise.
(ee)
Xxxxxxxx-Xxxxx
Act.
The
Company is in compliance with applicable requirements of the Xxxxxxxx-Xxxxx
Act
of 2002 and applicable rules and regulations promulgated by the Commission
thereunder in effect as of the date of this Agreement, except where such
noncompliance could not be reasonably expected to have, individually or in
the
aggregate, a Material Adverse Effect.
3.2 Representations
and Warranties of the Purchasers.
Each
Purchaser hereby, as to itself only and for no other Purchaser, represents
and
warrants to the Company as follows:
(a)
Organization;
Authority.
Such
Purchaser is an entity duly organized, validly existing and in good standing
under the laws of the jurisdiction of its organization with the requisite
corporate, limited liability company or partnership power and authority to
enter
into and to consummate the transactions contemplated by the Transaction
Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution, delivery and performance by such Purchaser of this Agreement
have
been duly authorized by all necessary corporate or limited liability company
action on the part of such Purchaser. This Agreement has been duly executed
by
such Purchaser and, when delivered by such Purchaser in accordance with terms
hereof, will constitutes the valid and legally binding obligation of such
Purchaser, enforceable against it in accordance with its terms.
(b)
Purchaser
Status.
At the
time such Purchaser was offered the Securities, it was, and at the date hereof
it is, an “accredited investor” as defined in Rule 501(a) under the Securities
Act. Such Purchaser is not a registered broker-dealer under Section 15 of
the
Exchange Act.
(c)
Experience
of such Purchaser.
Such
Purchaser, either alone or together with its representatives, has such
knowledge, sophistication and experience in business and financial matters
so as
to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment.
Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of
such
investment.
(d)
General
Solicitation.
Such
Purchaser is not purchasing the Securities as a result of any advertisement,
article, notice or other communication regarding the Securities published
in any
newspaper, magazine or similar media or broadcast over television or radio
or
presented at any seminar or any other general solicitation or general
advertisement.
14
The
Company acknowledges and agrees that each Purchaser does not make and has
not
made any representations or warranties with respect to the transactions
contemplated hereby other than those specifically set forth in this Section
3.2.
ARTICLE
IV.
OTHER
AGREEMENTS OF THE PARTIES
4.1 Transfer
Restrictions.
(a)
The
Securities may only be disposed of pursuant to an effective registration
statement under the Securities Act or pursuant to an available exemption
from
the registration requirements of the Securities Act, and in compliance with
any
applicable state securities laws. In connection with any transfer of Securities
other than pursuant to an effective registration statement or to the Company
or
pursuant to Rule 144(k), except as otherwise set forth herein, the Company
may
require the transferor to provide to the Company an opinion of counsel selected
by the transferor, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require
registration under the Securities Act. Notwithstanding the foregoing, the
Company hereby consents to and agrees to register on the books of the Company
and with its transfer agent, without any such legal opinion, any transfer
of
Securities by a Purchaser to an Affiliate of such Purchaser, provided that
the
transferee certifies to the Company that it is an “accredited investor” as
defined in Rule 501(a) under the Securities Act. As a condition of transfer,
any
such transferee shall agree in writing to be bound by the terms of this
Agreement and shall have the rights of a Purchaser under this
Agreement.
(b)
The
Purchasers agree to the imprinting, except as otherwise permitted by Section
4.1(c), the following legend on any certificate evidencing Securities:
[NEITHER]
THESE SECURITIES [NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE
EXERCISABLE] HAVE [NOT] BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN
EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE
“SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN COMPLIANCE WITH
APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS. NOTWITHSTANDING THE
FOREGOING, THESE SECURITIES AND THE SECURITIES ISSUABLE UPON CONVERSION OF
THESE
SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR
OTHER
LOAN OR FINANCING ARRANGEMENT SECURED BY SUCH SECURITIES.
15
(c)
Certificates
evidencing Securities shall not be required to contain the legend set forth
in
Section 4.1(b) or any other legend (i) while a Registration Statement covering
the resale of such Securities is effective under the Securities Act, or (ii)
following any sale of such Securities pursuant to Rule 144, or (iii) if such
Securities are eligible for sale under Rule 144(k), or (iv) if such legend
is
not required under applicable requirements of the Securities Act (including
judicial interpretations and pronouncements issued by the Staff of the
Commission). The Company shall cause its counsel to issue the legal opinion
included in the Transfer Agent Instructions to the Company’s transfer agent on
the Effective Date. Following the Effective Date or at such earlier time
as a
legend is no longer required for certain Securities, the Company will no
later
than three Trading Days following the delivery by a Purchaser to the Company
or
the Company’s transfer agent of a legended certificate representing such
Securities, deliver or cause to be delivered to such Purchaser a certificate
representing such Securities that is free from all restrictive and other
legends. The Company may not make any notation on its records or give
instructions to any transfer agent of the Company that enlarge the restrictions
on transfer set forth in Section 4.1(b). For so long as any Purchaser owns
Securities, the Company will not effect or publicly announce its intention
to
effect any exchange, recapitalization or other transaction that effectively
requires or rewards physical delivery of certificates evidencing the Common
Stock.
(d)
The
Company acknowledges and agrees that a Purchaser may from time to time pledge
or
grant a security interest in some or all of the Securities in connection
with a
bona fide margin agreement or other loan or financing arrangement secured
by the
Securities and, if required under the terms of such agreement, loan or
arrangement, such Purchaser may transfer pledged or secured Securities to
the
pledgees or secured parties. Such a pledge or transfer would not be subject
to
approval of the Company and no legal opinion of the pledgee, secured party
or
pledgor shall be required in connection therewith. Further, no notice shall
be
required of such pledge. At the appropriate Purchaser’s expense, the Company
will execute and deliver such reasonable documentation as a pledgee or secured
party of Securities may reasonably request in connection with a pledge or
transfer of the Securities, including the preparation and filing of any required
prospectus supplement under Rule 424(b)(3) of the Securities Act or other
applicable provision of the Securities Act to appropriately amend the list
of
selling stockholders thereunder.
4.2 Acknowledgment
of Dilution.
The
Company acknowledges that the issuance of the Securities (including the
Underlying Shares) will result in dilution of the outstanding shares of Common
Stock, which dilution may be substantial under certain market conditions.
The
Company further acknowledges that its obligations under the Transaction
Documents, including without limitation its obligation to issue the Securities
(including the Underlying Shares) pursuant to the Transaction Documents,
are
unconditional and absolute and not subject to any right of set off,
counterclaim, delay or reduction, regardless of the effect of any such dilution
or any claim that the Company may have against any Purchaser.
4.3 Furnishing
of Information.
As long
as any Purchaser owns Securities, the Company covenants to timely file (or
obtain extensions in respect thereof and file within the applicable grace
period) all reports required to be filed by the Company after the date hereof
pursuant to the Exchange Act. Upon the request of any Purchaser, the Company
shall deliver to such Purchaser a written certification of a duly authorized
officer as to whether it has complied with the preceding sentence. As long
as
any Purchaser owns Securities, if the Company is not required to file reports
pursuant to such laws, it will prepare and furnish to the Purchasers and
make
publicly available in accordance with paragraph (c) of Rule 144 such information
as is required for the Purchasers to sell the Securities under Rule 144.
The
Company further covenants that it will take such further action as any holder
of
Securities may reasonably request to satisfy the provisions of Rule 144
applicable to the issuer of securities relating to transactions for the sale
of
securities pursuant to Rule 144.
16
4.4 Integration.
The
Company shall not, and shall use its best efforts to ensure that no Affiliate
of
the Company shall, sell, offer for sale or solicit offers to buy or otherwise
negotiate in respect of any security (as defined in Section 2 of the Securities
Act) that would be integrated with the offer or sale of the Securities in
a
manner that would require the registration under the Securities Act of the
sale
of the Securities to the Purchasers or that would be integrated with the
offer
or sale of the Securities for purposes of the rules and regulations of any
Trading Market.
4.5 Reservation
and Listing of Securities.
(a)
The
Company shall maintain a reserve from its duly authorized shares of Common
Stock
for issuance pursuant to the Transaction Documents in such amount as may
be
required to fulfill its obligations in full under the Transaction Documents.
(b)
The
Company shall (i) in the time and manner required by each Trading Market,
prepare and file with such Trading Market an additional shares listing
application covering all of the shares of Common Stock issued or issuable
under
the Transaction Documents, (ii) take all steps necessary to cause such shares
of
Common Stock to be approved for listing on each Trading Market as soon as
possible thereafter, (iii) provide to the Purchasers evidence of such listing,
and (iv) maintain the listing of such Common Stock on each such Trading Market
or another Eligible Market.
(c)
In
the
case of a breach by the Company of Section 4.5(a), in addition to the other
remedies available to the Purchasers, the Purchasers shall have the right
to
require the Company to either: (i) use its best efforts to obtain the required
shareholder approval necessary to permit the issuance of such shares of Common
Stock as soon as is possible, but in any event not later than the 60th day
after
such notice, or (ii) within five Trading Days after delivery of a written
notice, pay cash to such Purchaser, as liquidated damages and not as a penalty,
in an amount equal to the number of shares of Common Stock not issuable by
the
Company times 115% of the average Closing Price over the five Trading Days
immediately prior to the date of such notice or, if greater, the five Trading
Days immediately prior to the date of payment (the “Cash
Amount”).
If the
exercising or converting Purchaser elects the first option under the preceding
sentence and the Company fails to obtain the required shareholder approval
on or
prior to the 60th day after such notice, then within three Trading Days after
such 60th day, the Company shall pay the Cash Amount to such Purchaser, as
liquidated damages and not as penalty.
4.6 Subsequent
Placements.
(a)
Other
than the Kraft Financing, from the date hereof until the Effective Date,
the
Company will not, directly or indirectly, offer, sell, grant any option to
purchase, or otherwise dispose of (or announce any offer, sale, grant or
any
option to purchase or other disposition of) any of its or the Subsidiaries’
equity or equity equivalent securities, including without limitation any
debt,
preferred stock or other instrument or security that is, at any time during
its
life and under any circumstances, convertible into or exchangeable or
exercisable for Common Stock or Common Stock Equivalents (any such offer,
sale,
grant, disposition or announcement being referred to as a “Subsequent
Placement”).
17
(b)
Other
than the Kraft Financing, from the Effective Date until 30 Trading Days after
the Effective Date (the “Blockout
Period”),
the
Company will not, directly or indirectly, effect any Subsequent Placement
except
as set forth in Section 4.6(e).
(c)
The
Blockout Period set forth in Section 4.6(b) above shall be extended for the
number of Trading Days during such period in which (i) trading in the Common
Stock is suspended by any Trading Market, (ii) the Registration Statement
is not
effective, or (iii) the prospectus included in the Registration Statement
may
not be used by the Purchasers for the resale of Registrable Securities
thereunder.
(d)
From
the
end of the Blockout Period and for so long as the Notes are outstanding,
the
Company will not, directly or indirectly, effect any Subsequent Placement
unless
the Company shall have first complied with this Section 4.6(d).
(i) The
Company shall deliver to each Purchaser a written notice (the “Offer”)
of any
proposed or intended issuance or sale or exchange of the securities being
offered (the “Offered
Securities”)
in a
Subsequent Placement, which Offer shall (w) identify and describe
the
Offered Securities, (x) describe the price and other terms upon which they
are
to be issued, sold or exchanged, and the number or amount of the Offered
Securities to be issued, sold or exchanged, (y) identify the Persons or entities
to which or with which the Offered Securities are to be offered, issued,
sold or
exchanged and (z) offer to issue and sell to or exchange with each Purchaser
(A)
a pro rata portion of the greater of (I) one-third (1/3) of the Offered
Securities and (II) Offered Securities with an aggregate principal amount
of
$2,500,000, in either case, based on such Purchaser’s pro rata portion of the
aggregate principal amount of the Notes purchased hereunder (the “Basic
Amount”),
and
(B) with respect to each Purchaser that elects to purchase its Basic Amount,
any
additional portion of the Offered Securities attributable to the Basic Amounts
of other Purchasers as such Purchaser shall indicate it will purchase or
acquire
should the other Purchasers subscribe for less than their Basic Amounts (the
“Undersubscription
Amount”).
(ii) To
accept
an Offer, in whole or in part, a Purchaser must deliver a written notice
to the
Company prior to the end of the 10 Trading Day period of the Offer, setting
forth the portion of the Purchaser’s Basic Amount that such Purchaser elects to
purchase and, if such Purchaser shall elect to purchase all of its Basic
Amount,
the Undersubscription Amount, if any, that such Purchaser elects to purchase
(in
either case, the “Notice
of Acceptance”).
If the
Basic Amounts subscribed for by all Purchasers are less than the total of
all of
the Basic Amounts, then each Purchaser who has set forth an Undersubcription
Amount in its Notice of Acceptance shall be entitled to purchase, in addition
to
the Basic Amounts subscribed for, the Undersubscription Amount it has subscribed
for; provided,
however,
that if
the Undersubscription Amounts subscribed for exceed the difference between
the
total of all the Basic Amounts and the Basic Amounts subscribed for (the
“Available
Undersubscription Amount”),
each
Purchaser who has subscribed for any Undersubscription Amount shall be entitled
to purchase on that portion of the Available Undersubscription Amount as
the
Basic Amount of such Purchaser bears to the total Basic Amounts of all
Purchasers that have subscribed for Undersubscription Amounts, subject to
rounding by the Board of Directors to the extent its deems reasonably
necessary.
18
(iii) The
Company shall have five (5) Trading Days from the expiration of the period
set
forth in Section 4.6(d)(ii) above to issue, sell or exchange all or any part
of
such Offered Securities as to which a Notice of Acceptance has not been given
by
the Purchasers (the “Refused
Securities”),
but
only to the offerees described in the Offer and only upon terms and conditions
(including, without limitation, unit prices and interest rates) that are
not
more favorable to the acquiring Person or Persons or less favorable to the
Company than those set forth in the Offer.
(iv) In
the
event the Company shall propose to sell less than all the Refused Securities
(any such sale to be in the manner and on the terms specified in Section
4.6(d)(iii) above), then each Purchaser may, at its sole option and in its
sole
discretion, reduce the number or amount of the Offered Securities specified
in
its Notice of Acceptance to an amount that shall be not less than the number
or
amount of the Offered Securities that the Purchaser elected to purchase pursuant
to Section 4.6(d)(ii) above multiplied by a fraction, (i) the numerator of
which
shall be the number or amount of Offered Securities the Company actually
proposes to issue, sell or exchange (including Offered Securities to be issued
or sold to Purchasers pursuant to Section 4.6(d)(ii) above prior to such
reduction) and (ii) the denominator of which shall be the original amount
of the
Offered Securities. In the event that any Purchaser so elects to reduce the
number or amount of Offered Securities specified in its Notice of Acceptance,
the Company may not issue, sell or exchange more than the reduced number
or
amount of the Offered Securities unless and until such securities have again
been offered to the Purchasers in accordance with Section 4.6(d)(i)
above.
(v) Upon
the
closing of the issuance, sale or exchange of all or less than all of the
Refused
Securities, the Purchasers shall acquire from the Company, and the Company
shall
issue to the Purchasers, the number or amount of Offered Securities specified
in
the Notices of Acceptance, as reduced pursuant to Section 4.6(d)(iv) above
if
the Purchasers have so elected, upon the terms and conditions specified in
the
Offer. The purchase by the Purchasers of any Offered Securities is subject
in
all cases to the preparation, execution and delivery by the Company and the
Purchasers of a purchase agreement relating to such Offered Securities
reasonably satisfactory in form and substance to the Purchasers and their
respective counsel.
(vi) Any
Offered Securities not acquired by the Purchasers or other persons in accordance
with Section 4.6(d)(iii) above may not be issued, sold or exchanged until
they
are again offered to the Purchasers under the procedures specified in this
Agreement.
19
(e)
The
restrictions contained in paragraphs (b) and (d) of this Section 4.6 shall
not
apply to Excluded Stock.
(f)
Notwithstanding
anything to the contrary set forth above, the Company shall comply with the
requirements set forth in Section 4.6(d) above in connection with the Kraft
Financing.
4.7 Conversion
Procedures.
The
form of Holder Conversion Notice included in the Notes set forth the totality
of
the procedures required by the Purchasers in order to convert the Notes.
No
additional legal opinion or other information or instructions shall be necessary
to enable the Purchasers to convert their Notes. The Company shall honor
conversions of the Notes and shall deliver Underlying Shares in accordance
with
the terms, conditions and time periods set forth in the Transaction
Documents.
4.8 Securities
Laws Disclosure; Publicity.
On or
before 8:30 a.m., New York time, on September 26, 2005, the Company
shall
issue a press release acceptable to the Purchasers disclosing all material
terms
of the transactions contemplated hereby. Within one Business Day of the date
of
this Agreement, the Company shall file a Current Report on Form 8-K with
the
Commission (the “8-K
Filing”)
describing the terms of the transactions contemplated by the Transaction
Documents and including as exhibits to such Current Report on Form 8-K this
Agreement and the form of Notes, in the form required by the Exchange Act.
Thereafter, the Company shall timely file any filings and notices required
by
the Commission or applicable law with respect to the transactions contemplated
hereby and provide copies thereof to the Purchasers promptly after filing.
The
Company shall, at least two Trading Days prior to the filing or dissemination
of
any disclosure required by this paragraph, provide a copy thereof to the
Purchasers for their review. The Company and the Purchasers shall consult
with
each other in issuing any press releases or otherwise making public statements
or filings and other communications with the Commission or any regulatory
agency
or Trading Market with respect to the transactions contemplated hereby, and
neither party shall issue any such press release or otherwise make any such
public statement, filing or other communication without the prior consent
of the
other, except if such disclosure is required by law, in which case the
disclosing party shall promptly provide the other party with prior notice
of
such public statement, filing or other communication. Notwithstanding the
foregoing, the Company shall not publicly disclose the name of any Purchaser,
or
include the name of any Purchaser in any filing with the Commission or any
regulatory agency or Trading Market, without the prior written consent of
such
Purchaser, except to the extent such disclosure (but not any disclosure as
to
the controlling Persons thereof) is required by law or Trading Market
regulations, in which case the Company shall provide the Purchasers with
prior
notice of such disclosure. The Company shall not, and shall cause each of
its
Subsidiaries and its and each of their respective officers, directors, employees
and agents not to, provide any Purchaser with any material nonpublic information
regarding the Company or any of its Subsidiaries from and after the filing
of
the 8-K Filing without the express written consent of such Purchaser. In
the
event of a breach of the foregoing covenant by the Company, any of its
Subsidiaries, or any of its or their respective officers, directors, employees
and agents, in addition to any other remedy provided herein or in the
Transaction Documents, a Purchaser shall have the right to require the Company
to make a public disclosure, in the form of a press release, public
advertisement or otherwise, of such material nonpublic information. No Purchaser
shall have any liability to the Company, its Subsidiaries, or any of its
or
their respective officers, directors, employees, shareholders or agents for
any
such disclosure. Subject to the foregoing, neither the Company nor any Purchaser
shall issue any press releases or any other public statements with respect
to
the transactions contemplated hereby; provided, however, that the Company
shall
be entitled, without the prior approval of any Purchaser, to make any press
release or other public disclosure with respect to such transactions (i)
in
substantial conformity with the 8-K Filing and contemporaneously therewith
and
(ii) as is required by applicable law and regulations (provided that in the
case
of clause (i) each Purchaser shall be consulted by the Company in connection
with any such press release or other public disclosure prior to its release).
Each press release disseminated during the 12 months prior to the Closing
Date
did not at the time of release contain any untrue statement of a material
fact
or omit to state a material fact required to be stated therein or necessary
in
order to make the statements therein, in light of the circumstances under
which
they were made, not misleading.
20
4.9 Use
of
Proceeds.
The
Company shall use the net proceeds from the sale of the Securities hereunder
for
working capital purposes and not for the satisfaction of any portion of the
Company’s debt (other than payment of trade payables and accrued expenses in the
ordinary course of the Company’s business and prior practices), to redeem any
Company equity or equity-equivalent securities or to settle any outstanding
litigation.
4.10 Indebtedness.
(a)
At
any
time after the date of this Agreement, neither the Company nor any Subsidiary
of
the Company shall incur any indebtedness, liability or obligation that is
senior
to or pari passu with the Notes in right of payment, whether with respect
to
principal, interest or upon liquidation or dissolution, or otherwise;
provided,
however,
that
notwithstanding the foregoing, the Company may, in the ordinary course of
business, incur indebtedness secured by purchase money security interests
(which
will be senior only as to the underlying assets covered thereby) and
indebtedness under capital lease obligations (which will be senior only as
to
the underlying assets covered thereby) (collectively, “Permitted
Indebtedness”).
(b)
The
provisions of this Section 4.10 shall terminate and be of no further force
or
effect upon the conversion or indefeasible repayment in full of the Notes
and
any and all expenses or liabilities relating thereto.
4.11 Repayment
of Notes.
Each of
the parties hereto agrees that all repayments of the Notes (including any
interest thereon) by the Company (other than by conversion of the Notes)
will be
paid pro rata to the holders thereof based upon the principal amount then
outstanding to each of such holders.
4.12 No
Impairment.
At all
times after the date hereof, the Company will not take or permit any action,
or
cause or permit any subsidiary to take or permit any action that impairs
or
adversely affects the rights of the Purchasers under the Agreement or the
Notes.
4.13 Fundamental
Changes.
In
addition to any other rights provided by law or set forth herein, from and
after
the date of this Agreement and for so long as any Notes remain outstanding,
the
Company shall not without first obtaining the approval (by vote or written
consent, as provided by law) of the holders of a majority of the outstanding
principal face amount of the Notes:
21
(a)
purchase,
redeem (other than pursuant to equity incentive agreements with non-officer
employees giving the Company the right to repurchase shares upon the termination
of services) or set aside any sums for the purchase or redemption of, or
declare
or pay any dividend (including a dividend payable in stock of the Company)
or
make any other distribution with respect to, any shares of capital stock
or any
other securities that are convertible into or exercisable for such
stock;
(b)
change
the nature of the Company’s business to any business which is fundamentally
distinct and separate from the business currently conducted by the Company;
or
(c)
cause
or
permit any subsidiary of the Company directly or indirectly to take any actions
described in clauses (a) through (b) above, other than issuing securities
to the
Company.
4.14 Indemnification.
(a)
If
any
Purchaser or any of its Affiliates or any officer, director, partner,
controlling person, employee or agent of a Purchaser or any of its Affiliates
(a
“Related
Person”)
becomes
involved in any capacity in any Proceeding brought by or against any Person
in
connection with or as a result of the transactions contemplated by the
Transaction Documents, the Company will indemnify and hold harmless such
Purchaser or Related Person for its reasonable legal and other expenses
(including the costs of any investigation, preparation and travel) and for
any
Losses incurred in connection therewith, as such expenses or Losses are
incurred, excluding only Losses that result directly from such Purchaser’s or
Related Person’s gross negligence or willful misconduct. In addition, the
Company shall indemnify and hold harmless each Purchaser and Related Person
from
and against any and all Losses, as incurred, arising out of or relating to
any
breach by the Company of any of the representations, warranties or covenants
made by the Company in this Agreement or any other Transaction Document,
or any
allegation by a third party that, if true, would constitute such a breach.
The
conduct of any Proceedings for which indemnification is available under this
paragraph shall be governed by Section 6.4(c) below. The indemnification
obligations of the Company under this paragraph shall be in addition to any
liability that the Company may otherwise have and shall be binding upon and
inure to the benefit of any successors, assigns, heirs and personal
representatives of the Purchasers and any such Related Persons. If the Company
breaches its obligations under any Transaction Document, then, in addition
to
any other liabilities the Company may have under any Transaction Document
or
applicable law, the Company shall pay or reimburse the Purchasers on demand
for
all costs of collection and enforcement (including reasonable attorneys fees
and
expenses). Without limiting the generality of the foregoing, the Company
specifically agrees to reimburse the Purchasers on demand for all costs of
enforcing the indemnification obligations in this paragraph.
4.15 Shareholders
Rights Plan.
No
claim will be made or enforced by the Company or any other Person that any
Purchaser is an “Acquiring Person” under any shareholders rights plan or similar
plan or arrangement in effect or hereafter adopted by the Company, or that
any
Purchaser could be deemed to trigger the provisions of any such plan or
arrangement, by virtue of receiving Underlying Shares under the Transaction
Documents or under any other agreement between the Company and the
Purchasers.
22
4.16 Delivery
of Certificates.
In
addition to any other rights available to a Purchaser, if the Company fails
to
deliver to such Purchaser a certificate representing Common Stock on the
date on
which delivery of such certificate is required by any Transaction Document,
and
if after such date such Purchaser purchases (in an open market transaction
or
otherwise) shares of Common Stock to deliver in satisfaction of a sale by
such
Purchaser of the shares that the Purchaser anticipated receiving from the
Company (a “Buy-In”),
then
the Company shall, within three Trading Days after such Purchaser’s request and
in such Purchaser’s discretion, either (i) pay cash to such Purchaser in an
amount equal to such Purchaser’s total purchase price (including brokerage
commissions, if any) for the shares of Common Stock so purchased (the
“Buy-In
Price”),
at
which point the Company’s obligation to deliver such certificate (and to issue
such Common Stock) shall terminate, or (ii) promptly honor its obligation
to
deliver to such Purchaser a certificate or certificates representing such
Common
Stock and pay cash to such Purchaser in an amount equal to the excess (if
any)
of the Buy-In Price over the product of (A) such number of shares of Common
Stock, times (B) the Closing Price on the date of the event giving rise to
the
Company’s obligation to deliver such certificate.
4.17 The
Company covenants that from and after the Closing Date, the Company will
not
issue any floating Common Stock Equivalents with an effective price or a
number
of underlying shares that floats or resets or otherwise varies or is subject
to
adjustment based (directly or indirectly) on market prices of the Common
Stock.
ARTICLE
V.
CONDITIONS
5.1 Conditions
Precedent to the Obligations of the Purchasers.
The
obligation of each Purchaser to acquire Securities at the Closing is subject
to
the satisfaction or waiver by such Purchaser, at or before the Closing, of
each
of the following conditions:
(a)
Representations
and Warranties.
The
representations and warranties of the Company contained herein shall be true
and
correct in all material respects as of the date when made and as of the Closing
as though made on and as of such date;
(b)
Performance.
The
Company and each other Purchaser shall have performed, satisfied and complied
in
all material respects with all covenants, agreements and conditions required
by
the Transaction Documents to be performed, satisfied or complied with by
it at
or prior to the Closing;
(c)
No
Injunction.
No
statute, rule, regulation, executive order, decree, ruling or injunction
shall
have been enacted, entered, promulgated or endorsed by any court or governmental
authority of competent jurisdiction that prohibits the consummation of any
of
the transactions contemplated by the Transaction Documents;
23
(d)
Adverse
Changes.
Since
the date of execution of this Agreement, no event or series of events shall
have
occurred that reasonably would be expected to have or result in a Material
Adverse Effect; and
(e)
No
Suspensions of Trading in Common Stock; Listing.
Trading
in the Common Stock shall not have been suspended by the Commission or any
Trading Market (except for any suspensions of trading of not more than one
Trading Day solely to permit dissemination of material information regarding
the
Company) at any time since the date of execution of this Agreement, and the
Common Stock shall have been at all times since such date listed for trading
on
an Eligible Market.
5.2 Conditions
Precedent to the Obligations of the Company.
The
obligation of the Company to sell Securities at the Closing is subject to
the
satisfaction or waiver by the Company, at or before the Closing, of each
of the
following conditions:
(a)
Representations
and Warranties.
The
representations and warranties of the Purchasers contained herein shall be
true
and correct in all material respects as of the date when made and as of the
Closing Date as though made on and as of such date;
(b)
Performance.
The
Purchasers shall have performed, satisfied and complied in all material respects
with all covenants, agreements and conditions required by the Transaction
Documents to be performed, satisfied or complied with by the Purchasers at
or
prior to the Closing; and
(c)
No
Injunction.
No
statute, rule, regulation, executive order, decree, ruling or injunction
shall
have been enacted, entered, promulgated or endorsed by any court or governmental
authority of competent jurisdiction that prohibits the consummation of any
of
the transactions contemplated by the Transaction Documents.
ARTICLE
VI.
REGISTRATION
RIGHTS
6.1 Shelf
Registration.
(a)
As
promptly as possible, and in any event on or prior to the Filing Date, the
Company shall prepare and file with the Commission a “shelf” Registration
Statement covering the resale of all Registrable Securities for an offering
to
be made on a continuous basis pursuant to Rule 415. If for any reason the
Commission does not permit all of the Registrable Securities to be included
in
such Registration Statement, then the Company shall prepare and file with
the
Commission a separate Registration Statement with respect to any such
Registrable Securities not included with the initial Registration Statements,
as
expeditiously as possible, but in no event later than the date which is 30
days
after the date on which the Commission shall indicate as being the first
date
such filing may be made. The Registration Statement shall be on Form S-3
and
shall contain (except if otherwise directed by the Purchasers) the “Plan of
Distribution”, substantially as attached hereto as Exhibit
E.
In the
event the Form S-3 is not available for the registration of the resale of
Registrable Securities hereunder, the Company shall (i) register the resale
of
the Registrable Securities on another appropriate form in accordance herewith
as
the Purchasers may consent and (ii) attempt to register the Registrable
Securities on Form S-3 as soon as such form is available, provided that the
Company shall maintain the effectiveness of the Registration Statements then
in
effect until such time as a Registration Statement on Form S-3 covering the
Registrable Securities has been declared effective by the Commission.
24
(b)
The
Company shall use its best efforts to cause the Registration Statement to
be
declared effective by the Commission as promptly as possible after the filing
thereof, but in any event prior to the Required Effectiveness Date, and shall
use its best efforts to keep the Registration Statement continuously effective
under the Securities Act until the fifth anniversary of the Effective Date
or
such earlier date when all Registrable Securities covered by such Registration
Statement have been sold publicly (the “Effectiveness
Period”).
(c)
The
Company shall notify each Purchaser in writing promptly (and in any event
within
one business day) after receiving notification from the Commission that the
Registration Statement has been declared effective.
(d)
If:
(i)
any Registration Statement is not filed on or prior to the Filing Date (if
the
Company files such Registration Statement without affording the Purchasers
the
opportunity to review and comment on the same as required by Section 6.2(a)
hereof, the Company shall not be deemed to have satisfied this clause (i)),
or
(ii) the Company fails to file with the Commission a request for acceleration
in
accordance with Rule 461 promulgated under the Securities Act, within five
Trading Days after the date that the Company is notified (orally or in writing,
whichever is earlier) by the Commission that a Registration Statement will
not
be “reviewed,” or will not be subject to further review, or (iii) the Company
fails to respond to any comments made by the Commission within 10 Trading
Days
after the receipt of such comments, or (iv) a Registration Statement filed
hereunder is not declared effective by the Commission by the Required
Effectiveness Date, or (v) after a Registration Statement is filed with and
declared effective by the Commission, such Registration Statement ceases
to be
effective as to all Registrable Securities to which it is required to relate
at
any time prior to the expiration of the Effectiveness Period without being
succeeded within 10 Trading Days by an amendment to such Registration Statement
or by a subsequent Registration Statement filed with and declared effective
by
the Commission, or (vi) an amendment to a Registration Statement is not filed
by
the Company with the Commission within ten Trading Days after the Commission’s
having notified the Company that such amendment is required in order for
such
Registration Statement to be declared effective, or (vii) the Common Stock
is
not listed or quoted, or is suspended from trading on the Nasdaq National
Market
for a period of three Trading Days (which need not be consecutive Trading
Days)
or (vii) the conversion rights of the Purchasers pursuant to the Notes are
suspended for any reason (any such failure or breach being referred to as
an
“Event,”
and
for purposes of clause (i), (iv) or (viii) the date on which such Event occurs,
or for purposes of clause (ii) the date on which such five Trading Day period
is
exceeded, or for purposes of clauses (iii), (v) or (vi) the date which such
ten
Trading Day-period is exceeded, or for purposes of clause (vii) the date
on
which such three Trading Day period is exceeded, being referred to as
“Event
Date”),
then:
(x) on each such Event Date the Company shall pay to each Purchaser an amount
in
cash, as partial liquidated damages and not as a penalty, equal to 2% of
the
aggregate purchase price paid by such Purchaser pursuant to the Purchase
Agreement; and (y) on each monthly anniversary of each such Event Date thereof
(if the applicable Event shall not have been cured by such date) until the
applicable Event is cured, the Company shall pay to each Purchaser an amount
in
cash, as partial liquidated damages and not as a penalty, equal to 2% of
the
aggregate purchase price paid by such Purchaser pursuant to the Purchase
Agreement. Such payments shall be in partial compensation to the Purchasers
and
shall not constitute the Purchaser’s exclusive remedy for such events. If the
Company fails to pay any liquidated damages pursuant to this Section in full
within seven days after the date payable, the Company will pay interest thereon
at a rate of 18% per annum (or such lesser maximum amount that is permitted
to
be paid by applicable law) to the Purchaser, accruing daily from the date
such
liquidated damages are due until such amounts, plus all such interest thereon,
are paid in full.
25
(e)
The
Company shall not, prior to the Effective Date of the Registration Statement,
prepare and file with the Commission a registration statement relating to
an
offering for its own account or the account of others under the Securities
Act
of any of its equity securities.
(f)
Notwithstanding
anything to the contrary, each Purchaser shall have the right to cause the
Company to pay any cash amounts due under Section 6.1(d) in freely tradable
and
registered Common Stock, including shares of Common Stock registered under
the
Registration Statement but not issued to the Purchasers. In the event that
a
Purchaser elects to receive shares of Common Stock, the number of shares
of
Common Stock to be issued to such Purchaser as such payment under Section
6.1(d)
shall be determined by dividing the aggregate amount of due to such Purchaser
by
the Market Price (as defined below) as of the date of payment, and rounding
up
to the nearest whole share. The term “Market Price” shall mean 90% of the
arithmetic average of the VWAP for the 20 Trading Days prior to the applicable
date of payment (not including such date).
(g)
If
the
Company issues to the Purchasers any Common Stock pursuant to the Transaction
Documents that is not included in the initial Registration Statement, then
the
Company shall file an additional Registration Statement covering such number
of
shares of Common Stock on or prior to the Filing Date and shall use it best
efforts, but in no event later than the Required Filing Date, to cause such
additional Registration Statement to become effective by the
Commission.
6.2 Registration
Procedures.
In
connection with the Company’s registration obligations hereunder, the Company
shall:
(a)
Not
less
than three Trading Days prior to the filing of a Registration Statement or
any
related Prospectus or any amendment or supplement thereto (including any
document that would be incorporated or deemed to be incorporated therein
by
reference), the Company shall (i) furnish to the Purchasers and Purchaser
Counsel copies of all such documents proposed to be filed, which documents
(other than those incorporated or deemed to be incorporated by reference)
will
be subject to the review of such Purchasers and Purchaser Counsel, and (ii)
cause its officers and directors, counsel and independent certified public
accountants to respond to such inquiries as shall be necessary, in the
reasonable opinion of respective counsel, to conduct a reasonable investigation
within the meaning of the Securities Act. The Company shall not file a
Registration Statement or any such Prospectus or any amendments or supplements
thereto to which Purchasers holding a majority of the Registrable Securities
shall reasonably object.
26
(b)
(i)
Prepare and file with the Commission such amendments, including post-effective
amendments, to each Registration Statement and the Prospectus used in connection
therewith as may be necessary to keep the Registration Statement continuously
effective as to the applicable Registrable Securities for the Effectiveness
Period and prepare and file with the Commission such additional Registration
Statements in order to register for resale under the Securities Act all of
the
Registrable Securities; (ii) cause the related Prospectus to be amended or
supplemented by any required Prospectus supplement, and as so supplemented
or
amended to be filed pursuant to Rule 424; (iii) respond as promptly as
reasonably possible, and in any event within ten days, to any comments received
from the Commission with respect to the Registration Statement or any amendment
thereto and as promptly as reasonably possible provide the Purchasers true
and
complete copies of all correspondence from and to the Commission relating
to the
Registration Statement; and (iv) comply in all material respects with the
provisions of the Securities Act and the Exchange Act with respect to the
disposition of all Registrable Securities covered by the Registration Statement
during the applicable period in accordance with the intended methods of
disposition by the Purchasers thereof set forth in the Registration Statement
as
so amended or in such Prospectus as so supplemented
(c)
Notify
the Purchasers of Registrable Securities to be sold and Purchaser Counsel
as
promptly as reasonably possible, and (if requested by any such Person) confirm
such notice in writing no later than one Trading Day thereafter, of any of
the
following events: (i) the Commission notifies the Company whether there will
be
a “review” of any Registration Statement; (ii) the Commission comments in
writing on any Registration Statement (in which case the Company shall deliver
to each Purchaser a copy of such comments and of all written responses thereto);
(iii) any Registration Statement or any post-effective amendment is declared
effective; (iv) the Commission or any other Federal or state governmental
authority requests any amendment or supplement to any Registration Statement
or
Prospectus or requests additional information related thereto; (v) the
Commission issues any stop order suspending the effectiveness of any
Registration Statement or initiates any Proceedings for that purpose; (vi)
the
Company receives notice of any suspension of the qualification or exemption
from
qualification of any Registrable Securities for sale in any jurisdiction,
or the
initiation or threat of any Proceeding for such purpose; or (vii) the financial
statements included or incorporated by reference in any Registration Statement
become ineligible for inclusion or incorporation therein or any statement
made
in any Registration Statement or Prospectus or any document incorporated
or
deemed to be incorporated therein by reference is untrue in any material
respect
or any revision to a Registration Statement, Prospectus or other document
is
required so that it will not contain any untrue statement of a material fact
or
omit to state any material fact required to be stated therein or necessary
to
make the statements therein, in the light of the circumstances under which
they
were made, not misleading.
(d)
Use
its
best efforts to avoid the issuance of or, if issued, obtain the withdrawal
of
(i) any order suspending the effectiveness of any Registration Statement,
or
(ii) any suspension of the qualification (or exemption from qualification)
of
any of the Registrable Securities for sale in any jurisdiction, as soon as
possible.
(e)
Furnish
to each Purchaser and Purchaser Counsel, without charge, at least one conformed
copy of each Registration Statement and each amendment thereto, including
financial statements and schedules, all documents incorporated or deemed
to be
incorporated therein by reference, and all exhibits to the extent requested
by
such Person (including those previously furnished or incorporated by reference)
promptly after the filing of such documents with the Commission.
27
(f)
Promptly
deliver to each Purchaser and Purchaser Counsel, without charge, as many
copies
of the Prospectus or Prospectuses (including each form of prospectus) and
each
amendment or supplement thereto as such Persons may reasonably request. The
Company hereby consents to the use of such Prospectus and each amendment
or
supplement thereto by each of the selling Purchasers in connection with the
offering and sale of the Registrable Securities covered by such Prospectus
and
any amendment or supplement thereto.
(g)
(i)
In
the time and manner required by each Trading Market, prepare and file with
such
Trading Market an additional shares listing application covering all of the
Registrable Securities; (ii) take all steps necessary to cause such Registrable
Securities to be approved for listing on each Trading Market as soon as possible
thereafter; (iii) provide to the Purchasers evidence of such listing; and
(iv)
maintain the listing of such Registrable Securities on each such Trading
Market
or another Eligible Market.
(h)
Prior
to
any public offering of Registrable Securities, use its best efforts to register
or qualify or cooperate with the selling Purchasers and Purchaser Counsel
in
connection with the registration or qualification (or exemption from such
registration or qualification) of such Registrable Securities for offer and
sale
under the securities or Blue Sky laws of such jurisdictions within the United
States as any Purchaser requests in writing, to keep each such registration
or
qualification (or exemption therefrom) effective during the Effectiveness
Period
and to do any and all other acts or things necessary or advisable to enable
the
disposition in such jurisdictions of the Registrable Securities covered by
a
Registration Statement.
(i)
Cooperate
with the Purchasers to facilitate the timely preparation and delivery of
certificates representing Registrable Securities to be delivered to a transferee
pursuant to a Registration Statement, which certificates shall be free, to
the
extent permitted by this Agreement, of all restrictive legends, and to enable
such Registrable Securities to be in such denominations and registered in
such
names as any such Purchasers may request.
(j)
Upon
the
occurrence of any event described in Section 6.2(c)(vii), as promptly as
reasonably possible, prepare a supplement or amendment, including a
post-effective amendment, to the Registration Statement or a supplement to
the
related Prospectus or any document incorporated or deemed to be incorporated
therein by reference, and file any other required document so that, as
thereafter delivered, neither the Registration Statement nor such Prospectus
will contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not
misleading.
(k)
Cooperate
with any due diligence investigation undertaken by the Purchasers in connection
with the sale of Registrable Securities, including, without limitation, by
making available any documents and information; provided that the Company
will
not deliver or make available to any Purchaser material, nonpublic information
unless such Purchaser specifically requests in advance to receive material,
nonpublic information in writing.
28
(l)
Comply
with all applicable rules and regulations of the Commission.
6.3 Registration
Expenses.
The
Company shall pay (or reimburse the Purchasers for) all fees and expenses
incident to the performance of or compliance with this Agreement by the Company,
including without limitation (a) all registration and filing fees and expenses,
including without limitation those related to filings with the Commission,
any
Trading Market and in connection with applicable state securities or Blue
Sky
laws, (b) printing expenses (including without limitation expenses of printing
certificates for Registrable Securities and of printing prospectuses requested
by the Purchasers), (c) messenger, telephone and delivery expenses, (d) fees
and
disbursements of counsel for the Company, (e) fees and expenses of all other
Persons retained by the Company in connection with the consummation of the
transactions contemplated by this Agreement, and (f) all listing fees to
be paid
by the Company to the Trading Market.
6.4 Indemnification.
(a)
Indemnification
by the Company.
The
Company shall, notwithstanding any termination of this Agreement, indemnify
and
hold harmless each Purchaser, the officers, directors, partners, members,
agents, brokers (including brokers who offer and sell Registrable Securities
as
principal as a result of a pledge or any failure to perform under a margin
call
of Common Stock), investment advisors and employees of each of them, each
Person
who controls any such Purchaser (within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act) and the officers, directors,
partners, members, agents and employees of each such controlling Person,
to the
fullest extent permitted by applicable law, from and against any and all
Losses,
as incurred, arising out of or relating to any untrue or alleged untrue
statement of a material fact contained in the Registration Statement, any
Prospectus or any form of prospectus or in any amendment or supplement thereto
or in any preliminary prospectus, or arising out of or relating to any omission
or alleged omission of a material fact required to be stated therein or
necessary to make the statements therein (in the case of any Prospectus or
form
of prospectus or supplement thereto, in the light of the circumstances under
which they were made) not misleading, except to the extent, but only to the
extent, that (i) such untrue statements, alleged untrue statements, omissions
or
alleged omissions are based solely upon information regarding such Purchaser
furnished in writing to the Company by such Purchaser expressly for use therein,
or to the extent that such information relates to such Purchaser or such
Purchaser’s proposed method of distribution of Registrable Securities and was
reviewed and expressly approved in writing by such Purchaser expressly for
use
in the Registration Statement, such Prospectus or such form of Prospectus
or in
any amendment or supplement thereto or (ii) in the case of an occurrence
of an
event of the type specified in Section 6.2(c)(v)-(vii), the use by such
Purchaser of an outdated or defective Prospectus after the Company has notified
such Purchaser in writing that the Prospectus is outdated or defective and
prior
to the receipt by such Purchaser of the Advice contemplated in Section 6.5.
In
no event shall the liability of any selling Purchaser hereunder be greater
in
amount than the dollar amount by which the net proceeds received by such
Purchaser upon the sale of the Registrable Securities giving rise to such
indemnification obligation exceeds the amount paid, directly or indirectly,
by
such Purchaser for such Registrable Securities.
29
(b)
Indemnification
by Purchasers.
Each
Purchaser shall, severally and not jointly, indemnify and hold harmless the
Company, its directors, officers, agents and employees, each Person who controls
the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, agents or employees
of
such controlling Persons, to the fullest extent permitted by applicable law,
from and against all Losses (as determined by a court of competent jurisdiction
in a final judgment not subject to appeal or review) arising solely out of
any
untrue statement of a material fact contained in the Registration Statement,
any
Prospectus, or any form of prospectus, or in any amendment or supplement
thereto, or arising solely out of any omission of a material fact required
to be
stated therein or necessary to make the statements therein (in the case of
any
Prospectus or form of prospectus or supplement thereto, in the light of the
circumstances under which they were made) not misleading to the extent, but
only
to the extent, that such untrue statement or omission is contained in any
information so furnished in writing by such Purchaser to the Company
specifically for inclusion in such Registration Statement or such Prospectus
or
to the extent that (i) such untrue statements or omissions are based solely
upon
information regarding such Purchaser furnished in writing to the Company
by such
Purchaser expressly for use therein, or to the extent that such information
relates to such Purchaser or such Purchaser’s proposed method of distribution of
Registrable Securities and was reviewed and expressly approved in writing
by
such Purchaser expressly for use in the Registration Statement, such Prospectus
or such form of Prospectus or in any amendment or supplement thereto or (ii)
in
the case of an occurrence of an event of the type specified in Section
6.2(c)(v)-(vii), the use by such Purchaser of an outdated or defective
Prospectus after the Company has notified such Purchaser in writing that
the
Prospectus is outdated or defective and prior to the receipt by such Purchaser
of the Advice contemplated in Section 6.5. In no event shall the liability
of
any selling Purchaser hereunder be greater in amount than the dollar amount
of
the net proceeds received by such Purchaser upon the sale of the Registrable
Securities giving rise to such indemnification obligation.
(c)
Conduct
of Indemnification Proceedings.
If any
Proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an “Indemnified
Party”),
such
Indemnified Party shall promptly notify the Person from whom indemnity is
sought
(the “Indemnifying
Party”)
in
writing, and the Indemnifying Party shall assume the defense thereof, including
the employment of counsel reasonably satisfactory to the Indemnified Party
and
the payment of all fees and expenses incurred in connection with defense
thereof; provided, that the failure of any Indemnified Party to give such
notice
shall not relieve the Indemnifying Party of its obligations or liabilities
pursuant to this Agreement, except (and only) to the extent that it shall
be
finally determined by a court of competent jurisdiction (which determination
is
not subject to appeal or further review) that such failure shall have
proximately and materially adversely prejudiced the Indemnifying
Party.
An
Indemnified Party shall have the right to employ separate counsel in any
such
Proceeding and to participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Indemnified Party or Parties
unless: (i) the Indemnifying Party has agreed in writing to pay such fees
and
expenses; or (ii) the Indemnifying Party shall have failed promptly to assume
the defense of such Proceeding and to employ counsel reasonably satisfactory
to
such Indemnified Party in any such Proceeding; or (iii) the named parties
to any
such Proceeding (including any impleaded parties) include both such Indemnified
Party and the Indemnifying Party, and such Indemnified Party shall have been
advised by counsel that a conflict of interest is likely to exist if the
same
counsel were to represent such Indemnified Party and the Indemnifying Party
(in
which case, if such Indemnified Party notifies the Indemnifying Party in
writing
that it elects to employ separate counsel at the expense of the Indemnifying
Party, the Indemnifying Party shall not have the right to assume the defense
thereof and such counsel shall be at the expense of the Indemnifying Party).
The
Indemnifying Party shall not be liable for any settlement of any such Proceeding
effected without its written consent, which consent shall not be unreasonably
withheld. No Indemnifying Party shall, without the prior written consent
of the
Indemnified Party, effect any settlement of any pending Proceeding in respect
of
which any Indemnified Party is a party, unless such settlement includes an
unconditional release of such Indemnified Party from all liability on claims
that are the subject matter of such Proceeding.
30
All
fees
and expenses of the Indemnified Party (including reasonable fees and expenses
to
the extent incurred in connection with investigating or preparing to defend
such
Proceeding in a manner not inconsistent with this Section) shall be paid
to the
Indemnified Party, as incurred, within ten Trading Days of written notice
thereof to the Indemnifying Party (regardless of whether it is ultimately
determined that an Indemnified Party is not entitled to indemnification
hereunder; provided, that the Indemnifying Party may require such Indemnified
Party to undertake to reimburse all such fees and expenses to the extent
it is
finally judicially determined that such Indemnified Party is not entitled
to
indemnification hereunder).
(d)
Contribution.
If a
claim for indemnification under Section 6.4(a) or (b) is unavailable to an
Indemnified Party (by reason of public policy or otherwise), then each
Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall
contribute to the amount paid or payable by such Indemnified Party as a result
of such Losses, in such proportion as is appropriate to reflect the relative
fault of the Indemnifying Party and Indemnified Party in connection with
the
actions, statements or omissions that resulted in such Losses as well as
any
other relevant equitable considerations. The relative fault of such Indemnifying
Party and Indemnified Party shall be determined by reference to, among other
things, whether any action in question, including any untrue or alleged untrue
statement of a material fact or omission or alleged omission of a material
fact,
has been taken or made by, or relates to information supplied by, such
Indemnifying Party or Indemnified Party, and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent such
action, statement or omission. The amount paid or payable by a party as a
result
of any Losses shall be deemed to include, subject to the limitations set
forth
in Section 6.4(c), any reasonable attorneys’ or other reasonable fees or
expenses incurred by such party in connection with any Proceeding to the
extent
such party would have been indemnified for such fees or expenses if the
indemnification provided for in this Section was available to such party
in
accordance with its terms.
The
parties hereto agree that it would not be just and equitable if contribution
pursuant to this Section 6.4(d) were determined by pro rata allocation or
by any
other method of allocation that does not take into account the equitable
considerations referred to in the immediately preceding paragraph.
Notwithstanding the provisions of this Section 6.4(d), no Purchaser shall
be
required to contribute, in the aggregate, any amount in excess of the amount
by
which the proceeds actually received by such Purchaser from the sale of the
Registrable Securities subject to the Proceeding exceeds the amount of any
damages that such Purchaser has otherwise been required to pay by reason
of such
untrue or alleged untrue statement or omission or alleged omission. No Person
guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
of
the Securities Act) shall be entitled to contribution from any Person who
was
not guilty of such fraudulent misrepresentation.
31
The
indemnity and contribution agreements contained in this Section are in addition
to any liability that the Indemnifying Parties may have to the Indemnified
Parties.
6.5 Dispositions.
Each
Purchaser agrees that it will comply with the prospectus delivery requirements
of the Securities Act as applicable to it in connection with sales of
Registrable Securities pursuant to the Registration Statement. Each Purchaser
further agrees that, upon receipt of a notice from the Company of the occurrence
of any event of the kind described in Sections 6.2(c)(v), (vi) or (vii),
such
Purchaser will discontinue disposition of such Registrable Securities under
the
Registration Statement until such Purchaser’s receipt of the copies of the
supplemented Prospectus and/or amended Registration Statement contemplated
by
Section 6.2(j), or until it is advised in writing (the “Advice”) by the Company
that the use of the applicable Prospectus may be resumed, and, in either
case,
has received copies of any additional or supplemental filings that are
incorporated or deemed to be incorporated by reference in such Prospectus
or
Registration Statement. The Company may provide appropriate stop orders to
enforce the provisions of this paragraph.
6.6 No
Piggyback on Registrations.
Except
as set forth on Schedule 3.1(x) neither the Company nor any of its security
holders (other than the Purchasers in such capacity pursuant hereto) may
include
securities of the Company in the Registration Statement other than the
Registrable Securities, and the Company shall not after the date hereof enter
into any agreement providing any such right to any of its security
holders.
6.7 Piggy-Back
Registrations.
If at
any time during the Effectiveness Period there is not an effective Registration
Statement covering all of the Registrable Securities and the Company shall
determine to prepare and file with the Commission a registration statement
relating to an offering for its own account or the account of others under
the
Securities Act of any of its equity securities, other than on Form S-4 or
Form
S-8 (each as promulgated under the Securities Act) or their then equivalents
relating to equity securities to be issued solely in connection with any
acquisition of any entity or business or equity securities issuable in
connection with stock option or other employee benefit plans, then the Company
shall send to each Purchaser written notice of such determination and if,
within
fifteen days after receipt of such notice, any such Purchaser shall so request
in writing, the Company shall include in such registration statement all
or any
part of such Registrable Securities such Purchaser requests to be
registered.
ARTICLE
VII.
MISCELLANEOUS
7.1 Termination.
This
Agreement may be terminated by the Company or any Purchaser, by written notice
to the other parties, if the Closing has not been consummated by the third
Trading Day following the date of this Agreement; provided that no such
termination will affect the right of any party to xxx for any breach by the
other party (or parties).
32
7.2 Fees
and Expenses.
At the
Closing, the Company shall pay to Iroquois Master Fund Ltd. an aggregate
of
$25,000 for their legal fees and expenses incurred in connection with the
preparation and negotiation of this Agreement. In lieu of the foregoing
remaining payment, Iroquois Master Fund Ltd. may retain such amount at the
Closing. Except as expressly set forth in the Transaction Documents to the
contrary, each party shall pay the fees and expenses of its advisers, counsel,
accountants and other experts, if any, and all other expenses incurred by
such
party incident to the negotiation, preparation, execution, delivery and
performance of this Agreement. The Company shall pay all transfer agent fees,
stamp taxes and other taxes and duties levied in connection with the issuance
of
any Securities.
7.3 Entire
Agreement.
The
Transaction Documents, together with the Exhibits and Schedules thereto,
contain
the entire understanding of the parties with respect to the subject matter
hereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged
into such documents, exhibits and schedules. At or after the Closing, and
without further consideration, the Company will execute and deliver to the
Purchasers such further documents as may be reasonably requested in order
to
give practical effect to the intention of the parties under the Transaction
Documents.
7.4 Notices.
Any and
all notices or other communications or deliveries required or permitted to
be
provided hereunder shall be in writing and shall be deemed given and effective
on the earliest of (i) the date of transmission, if such notice or communication
is delivered via facsimile at the facsimile number specified in this Section
prior to 6:30 p.m. (New York City time) on a Trading Day, (ii) the Trading
Day
after the date of transmission, if such notice or communication is delivered
via
facsimile at the facsimile number specified in this Agreement later than
6:30
p.m. (New York City time) on any date and earlier than 11:59 p.m. (New York
City
time) on such date, (iii) the Trading Day following the date of mailing,
if sent
by nationally recognized overnight courier service, or (iv) upon actual receipt
by the party to whom such notice is required to be given. The address for
such
notices and communications shall be as follows:
33
If
to the Company:
|
American
United Global, Inc..
|
000
Xxxxxxx Xxxxxx - #000
|
|
Xxxxxx,
XX 00000
|
|
Attn: Xxxxxx
Xxxxx, CEO
|
|
Fax
No.: (000)
000-0000
|
|
With
a copy to:
|
With
a copy to:
|
Sichenzia
Xxxx Xxxxxxxx Xxxxxxx LLP
|
|
0000
Xxxxxx xx xxx Xxxxxxxx
|
|
Xxx
Xxxx, Xxx Xxxx 00000
|
|
Attn:
Xxxxxxx
X. Xxxxxxxx, Esq.
|
|
Fax
No.: 000-000-0000
|
|
If
to the Purchasers:
|
To
the address set forth under such Purchaser’s name on the signature pages
attached hereto.
|
or
such
other address as may be designated in writing hereafter, in the same manner,
by
such Person.
7.5 Amendments;
Waivers.
No
provision of this Agreement may be waived or amended except in a written
instrument signed, in the case of an amendment, by the Company and each of
the
Purchasers or, in the case of a waiver, by the party against whom enforcement
of
any such waiver is sought. No waiver of any default with respect to any
provision, condition or requirement of this Agreement shall be deemed to
be a
continuing waiver in the future or a waiver of any subsequent default or
a
waiver of any other provision, condition or requirement hereof, nor shall
any
delay or omission of either party to exercise any right hereunder in any
manner
impair the exercise of any such right. Notwithstanding the foregoing, a waiver
or consent to depart from the provisions hereof with respect to a matter
that
relates exclusively to the rights of Purchasers under Article VI and that
does
not directly or indirectly affect the rights of other Purchasers may be given
by
Purchasers holding at least a majority of the Registrable Securities to which
such waiver or consent relates.
7.6 Construction.
The
headings herein are for convenience only, do not constitute a part of this
Agreement and shall not be deemed to limit or affect any of the provisions
hereof. The language used in this Agreement will be deemed to be the language
chosen by the parties to express their mutual intent, and no rules of strict
construction will be applied against any party.
7.7 Successors
and Assigns.
This
Agreement shall be binding upon and inure to the benefit of the parties and
their successors and permitted assigns. The Company may not assign this
Agreement or any rights or obligations hereunder without the prior written
consent of the Purchasers. Any Purchaser may assign its rights under this
Agreement to any Person to whom such Purchaser assigns or transfers any
Securities, provided such transferee agrees in writing to be bound, with
respect
to the transferred Securities, by the provisions hereof that apply to the
“Purchasers.” Notwithstanding anything to the contrary herein, Securities may be
assigned to any Person in connection with a bona fide margin account or other
loan or financing arrangement secured by such Securities.
34
7.8 No
Third-Party Beneficiaries.
This
Agreement is intended for the benefit of the parties hereto and their respective
successors and permitted assigns and is not for the benefit of, nor may any
provision hereof be enforced by, any other Person, except that each Related
Person is an intended third party beneficiary of Section 4.14 and each
Indemnified Party is an intended third party beneficiary of Section 6.4 and
(in
each case) may enforce the provisions of such Sections directly against the
parties with obligations thereunder.
7.9 Governing
Law; Venue; Waiver of Jury Trial.
All
questions concerning the construction, validity, enforcement and interpretation
of this Agreement shall be governed by and construed and enforced in accordance
with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal
proceedings concerning the interpretations, enforcement and defense of the
transactions contemplated by any of the Transaction Documents (whether brought
against a party hereto or its respective Affiliates, directors, officers,
shareholders, employees or agents) shall be commenced exclusively in the
state
and federal courts sitting in the City of New York, Borough of Manhattan.
Each
party hereto hereby irrevocably submits to the exclusive jurisdiction of
the
state and federal courts sitting in the City of New York, Borough of Manhattan
for the adjudication of any dispute hereunder or in connection herewith or
with
any transaction contemplated hereby or discussed herein (including with respect
to the enforcement of any of this Agreement), and hereby irrevocably waives,
and
agrees not to assert in any suit, action or proceeding, any claim that it
is not
personally subject to the jurisdiction of any such court, that such suit,
action
or proceeding is improper. Each party hereto hereby irrevocably waives personal
service of process and consents to process being served in any such suit,
action
or proceeding by mailing a copy thereof via registered or certified mail
or
overnight delivery (with evidence of delivery) to such party at the address
in
effect for notices to it under this Agreement and agrees that such service
shall
constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process
in any manner permitted by law. Each party hereto hereby irrevocably waives,
to
the fullest extent permitted by applicable law, any and all right to trial
by
jury in any legal proceeding arising out of or relating to this Agreement
or any
of the Transaction Documents or the transactions contemplated hereby or thereby.
If either party shall commence an action or proceeding to enforce any provisions
of this Agreement or any Transaction Document, then the prevailing party
in such
action or proceeding shall be reimbursed by the other party for its reasonable
attorneys fees and other reasonable costs and expenses incurred with the
investigation, preparation and prosecution of such action or
proceeding.
7.10 Survival.
The
representations, warranties, agreements and covenants contained herein shall
survive the Closing and the delivery, exercise and/or conversion of the
Securities, as applicable.
7.11 Execution.
This
Agreement may be executed in two or more counterparts, all of which when
taken
together shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered
to the
other party, it being understood that both parties need not sign the same
counterpart. In the event that any signature is delivered by facsimile
transmission, such signature shall create a valid and binding obligation
of the
party executing (or on whose behalf such signature is executed) the same
with
the same force and effect as if such facsimile signature page were an original
thereof.
35
7.12 Severability.
If any
provision of this Agreement is held to be invalid or unenforceable in any
respect, the validity and enforceability of the remaining terms and provisions
of this Agreement shall not in any way be affected or impaired thereby and
the
parties will attempt to agree upon a valid and enforceable provision that
is a
reasonable substitute therefor, and upon so agreeing, shall incorporate such
substitute provision in this Agreement.
7.13 Rescission
and Withdrawal Right.
Notwithstanding anything to the contrary contained in (and without limiting
any
similar provisions of) the Transaction Documents, whenever any Purchaser
exercises a right, election, demand or option under a Transaction Document
and
the Company does not timely perform its related obligations within the periods
therein provided, then such Purchaser may rescind or withdraw, in its sole
discretion from time to time upon written notice to the Company, any relevant
notice, demand or election in whole or in part without prejudice to its future
actions and rights.
7.14 Replacement
of Securities.
If any
certificate or instrument evidencing any Securities is mutilated, lost, stolen
or destroyed, the Company shall issue or cause to be issued in exchange and
substitution for and upon cancellation thereof, or in lieu of and substitution
therefor, a new certificate or instrument, but only upon receipt of evidence
reasonably satisfactory to the Company of such loss, theft or destruction
and
customary and reasonable indemnity, if requested. The applicants for a new
certificate or instrument under such circumstances shall also pay any reasonable
third-party costs associated with the issuance of such replacement
Securities.
7.15 Remedies.
In
addition to being entitled to exercise all rights provided herein or granted
by
law, including recovery of damages, each of the Purchasers and the Company
will
be entitled to specific performance under the Transaction Documents. The
parties
agree that monetary damages may not be adequate compensation for any loss
incurred by reason of any breach of obligations described in the foregoing
sentence and hereby agrees to waive in any action for specific performance
of
any such obligation the defense that a remedy at law would be
adequate.
7.16 Payment
Set Aside.
To the
extent that the Company makes a payment or payments to any Purchaser hereunder
or any Purchaser enforces or exercises its rights hereunder or thereunder,
and
such payment or payments or the proceeds of such enforcement or exercise
or any
part thereof are subsequently invalidated, declared to be fraudulent or
preferential, set aside, recovered from, disgorged by or are required to
be
refunded, repaid or otherwise restored to the Company by a trustee, receiver
or
any other person under any law (including, without limitation, any bankruptcy
law, state or federal law, common law or equitable cause of action), then
to the
extent of any such restoration the obligation or part thereof originally
intended to be satisfied shall be revived and continued in full force and
effect
as if such payment had not been made or such enforcement or setoff had not
occurred.
7.17 Usury.
To the
extent it may lawfully do so, the Company hereby agrees not to insist upon
or
plead or in any manner whatsoever claim, and will resist any and all efforts
to
be compelled to take the benefit or advantage of, usury laws wherever enacted,
now or at any time hereafter in force, in connection with any claim, action
or
proceeding that may be brought by any Purchaser in order to enforce any right
or
remedy under any Transaction Document. Notwithstanding any provision to the
contrary contained in any Transaction Document, it is expressly agreed and
provided that the total liability of the Company under the Transaction Documents
for payments in the nature of interest shall not exceed the maximum lawful
rate
authorized under applicable law (the “Maximum
Rate”),
and,
without limiting the foregoing, in no event shall any rate of interest or
default interest, or both of them, when aggregated with any other sums in
the
nature of interest that the Company may be obligated to pay under the
Transaction Documents exceed such Maximum Rate. It is agreed that if the
maximum
contract rate of interest allowed by law and applicable to the Transaction
Documents is increased or decreased by statute or any official governmental
action subsequent to the date hereof, the new maximum contract rate of interest
allowed by law will be the Maximum Rate of interest applicable to the
Transaction Documents from the effective date forward, unless such application
is precluded by applicable law. If under any circumstances whatsoever, interest
in excess of the Maximum Rate is paid by the Company to any Purchaser with
respect to indebtedness evidenced by the Transaction Documents, such excess
shall be applied by such Purchaser to the unpaid principal balance of any
such
indebtedness or be refunded to the Company, the manner of handling such excess
to be at such Purchaser’s election.
36
7.18 Independent
Nature of Purchasers’ Obligations and Rights.
The
obligations of each Purchaser under any Transaction Document are several
and not
joint with the obligations of any other Purchaser, and no Purchaser shall
be
responsible in any way for the performance of the obligations of any other
Purchaser under any Transaction Document. The decision of each Purchaser
to
purchase Notes pursuant to this Agreement has been made by such Purchaser
independently of any other Purchaser and independently of any information,
materials, statements or opinions as to the business, affairs, operations,
assets, properties, liabilities, results of operations, condition (financial
or
otherwise) or prospects of the Company or of the Subsidiary which may have
been
made or given by any other Purchaser or by any agent or employee of any other
Purchaser, and no Purchaser or any of its agents or employees shall have
any
liability to any other Purchaser (or any other person) relating to or arising
from any such information, materials, statements or opinions. Nothing contained
herein or in any Transaction Document, and no action taken by any Purchaser
pursuant thereto, shall be deemed to constitute the Purchasers as a partnership,
an association, a joint venture or any other kind of entity, or create a
presumption that the Purchasers are in any way acting in concert or as a
group
with respect to such obligations or the transactions contemplated by the
Transaction Document. The Company hereby confirms that it understands and
agrees
that the Purchasers are not acting as a “group” as that term is used in Section
13(d) of the Exchange Act. Each Purchaser acknowledges that no other Purchaser
has acted as agent for such Purchaser in connection with making its investment
hereunder and that no other Purchaser will be acting as agent of such Purchaser
in connection with monitoring its investment hereunder. Each Purchaser shall
be
entitled to independently protect and enforce its rights, including without
limitation the rights arising out of this Agreement or out of the other
Transaction Documents, and it shall not be necessary for any other Purchaser
to
be joined as an additional party in any proceeding for such purpose. Each
Purchaser represents that it has been represented by its own separate legal
counsel in its review and negotiations of this Agreement and the Transaction
Documents and each party represents and confirms that Proskauer Rose LLP
represents only Iroquois Master Trust, Ltd. in connection with this Agreement
and the Transaction Documents.
37
7.19 Adjustments
in Share Numbers and Prices.
In the
event of any stock split, subdivision, dividend or distribution payable in
shares of Common Stock (or other securities or rights convertible into, or
entitling the holder thereof to receive directly or indirectly shares of
Common
Stock), combination or other similar recapitalization or event occurring
after
the date hereof, each reference in this Agreement to a number of shares or
a
price per share shall be amended to appropriately account for such
event.
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK
SIGNATURE
PAGES FOLLOW]
38
IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase
Agreement to be duly executed by their respective authorized signatories
as of
the date first indicated above.
AMERICAN
UNITED GLOBAL, INC.
|
||
|
|
|
By: | /s/ | |
|
||
Title: |
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK
SIGNATURE
PAGES OF PURCHASERS FOLLOW.]
39
IROQUOIS
MASTER FUND LTD.
|
||
|
|
|
By: | /s/ | |
|
||
Title: | ||
Purchase
Price: $175,000
|
||
Notes
Principal Amount: $175,000
|
||
Shares: 175,000
|
||
Address
for Notice:
|
||
Iroquois
Master Fund Ltd.
|
||
000
Xxxxxxxxx Xxxxxx
|
||
00xx
Xxxxx
|
||
Xxx
Xxxx, XX 00000
|
||
Facsimile
No.: (000)
000-0000
|
||
Telephone
No.: (000)
000-0000
|
||
Attn.: Xxxxxx
Xxxxxxxxx
|
||
With a copy to: | ||
Proskauer
Rose LLP
|
||
0000
Xxxxxxxx
|
||
Xxx
Xxxx, XX 00000-0000
|
||
Facsimile
No.: (000) 000-0000
|
||
Attn:
Xxxx X. Xxxxxxx, Esq.
|
40
LILAC VENTURES MASTER FUND | ||
|
|
|
By: | /s/ | |
|
||
Title: | ||
Purchase
Price: $175,000
|
||
Notes
Principal Amount: $175,000
|
||
Shares: 175,000
|
||
Address
for Notice:
Lilac
Ventures Master Fund
000
Xxxxx Xxxxxx, 00xx
Xxxxx
Xxx
Xxxx, XX 00000
Facsimile
No.: (000) 000-0000
Telephone
No.: (000) 000-0000
Attn:
Xxxxx Xxxxxxxxx
|
||
41
SMITHFIELD
FIDUCIARY LLC
|
||
|
|
|
By: | /s/ | |
|
||
Title: | ||
Purchase
Price: $175,000
|
||
Notes
Principal Amount: $175,000
|
||
Shares: 175,000
|
||
Address
for Notice:
Smithfield
Fiduciary LLC
c/o
Highbridge Capital Management LLC
0
Xxxx 00xx
Xxxxxx, 00xx
Xxxxx
Xxx
Xxxx, XX 00000
Facsimile
No.: (000) 000-0000
Telephone
No.: (000) 000-0000
Attn:
Xxxx Chill
|
42
Exhibits:
A. |
Form
of Note
|
B. |
Security
Agreement
|
C. |
Transfer
Agent Instructions
|
D. |
Opinion
of Company Counsel
|
E. |
Plan
of Distribution
|
F. |
Personal
Guaranty
|
Schedules:
3.1(a) |
Subsidiaries
|
3.1(g) |
Capitalization
|
3.1(h) |
SEC
Reports; Financial Statements
|
3.1(j) |
Litigation
|
3.1(t) |
Certain
Fees
|
3.1(x) |
Registration
Rights
|
3.1(w) |
Listing
and Maintenance Requirements
|
3.1(dd) |
Ranking
|
43